,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,1,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line,Confirmatory,,
1,3,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line,Confirmatory,,
2,5,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line,Confirmatory,,
3,7,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line,Confirmatory,,
4,9,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line,Confirmatory,,
5,11,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-18 Non-Small Cell Lung cell line,Confirmatory,,
6,13,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line,Confirmatory,,
7,15,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line,Confirmatory,,
8,17,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the LXFL 529 Non-Small Cell Lung cell line,Confirmatory,,
9,19,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line,Confirmatory,,
10,21,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line,Confirmatory,,
11,23,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line,Confirmatory,,
12,25,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line,Confirmatory,,
13,27,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the M19-MEL Melanoma cell line,Confirmatory,,
14,29,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line,Confirmatory,,
15,31,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line,Confirmatory,,
16,33,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line,Confirmatory,,
17,35,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line,Confirmatory,,
18,37,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line,Confirmatory,,
19,39,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line,Confirmatory,,
20,41,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the PC-3 Prostate cell line,Confirmatory,,
21,43,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line,Confirmatory,,
22,45,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line,Confirmatory,,
23,47,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line,Confirmatory,,
24,49,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line,Confirmatory,,
25,51,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the XF 498 Central Nervous System cell line,Confirmatory,,
26,53,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line,Confirmatory,,
27,55,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line,Confirmatory,,
28,57,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-78 Central Nervous System cell line,Confirmatory,,
29,59,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line,Confirmatory,,
30,61,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 273 Small Cell Lung cell line,Confirmatory,,
31,63,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 114 Small Cell Lung cell line,Confirmatory,,
32,65,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line,Confirmatory,,
33,67,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line,Confirmatory,,
34,69,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DLD-1 Colon cell line,Confirmatory,,
35,71,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line,Confirmatory,,
36,73,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line,Confirmatory,,
37,75,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM20L2 Colon cell line,Confirmatory,,
38,77,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line,Confirmatory,,
39,79,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line,Confirmatory,,
40,81,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line,Confirmatory,,
41,83,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line,Confirmatory,,
42,85,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-435 Breast cell line,Confirmatory,,
43,87,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line,Confirmatory,,
44,89,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the BT-549 Breast cell line,Confirmatory,,
45,91,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the T-47D Breast cell line,Confirmatory,,
46,93,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI/ADR-RES Breast cell line,Confirmatory,,
47,95,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-231/ATCC Breast cell line,Confirmatory,,
48,97,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HS 578T Breast cell line,Confirmatory,,
49,99,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line,Confirmatory,,
50,101,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line,Confirmatory,,
51,103,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line,Confirmatory,,
52,105,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line,Confirmatory,,
53,107,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line,Confirmatory,,
54,109,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line,Confirmatory,,
55,111,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the P388 Leukemia cell line,Confirmatory,,
56,113,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line,Confirmatory,,
57,115,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line,Confirmatory,,
58,117,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the P388/ADR Leukemia cell line,Confirmatory,,
59,119,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line,Confirmatory,,
60,121,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line,Confirmatory,,
61,123,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line,Confirmatory,,
62,125,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line,Confirmatory,,
63,127,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SN12K1 Renal cell line,Confirmatory,,
64,129,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line,Confirmatory,,
65,131,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line,Confirmatory,,
66,133,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line,Confirmatory,,
67,135,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF-631 Renal cell line,Confirmatory,,
68,137,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line,Confirmatory,,
69,139,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line,Confirmatory,,
70,141,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line,Confirmatory,,
71,143,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line,Confirmatory,,
72,145,1,1,,87150,2907,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line,Confirmatory,,
73,155,1,1,,87150,2907,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
74,157,1,1,,87150,2907,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
75,161,1,1,,87150,2907,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
76,165,1,1,,87150,2907,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
77,167,1,1,,87150,2907,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
78,175,1,1,,87150,2907,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
79,179,1,1,,87150,2907,Inactive,,,,,NCI AIDS Antiviral Assay,Confirmatory,,
80,180,1,1,,87150,2907,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Adenocarcinoma 755 (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
81,182,1,1,,87150,2907,Active,,,,,"NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia resistant to Adriamycin; NSC 123127, Developed at Scr 06 and 41 (intraperitoneal) in B6D2F1 (BDF1) mice",Other,,
82,184,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  ADJ-PC-6 (intraperitoneal) in BALB/cJ mice,Other,,
83,186,1,1,,87150,2907,Unspecified,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Nontumored Animals (Toxicity Test) in B6D2F1 (BDF1) mice,Other,,
84,188,1,1,,87150,2907,Unspecified,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Nontumored Animals (Toxicity Test) in CD2F1 (CDF1) mice,Other,,
85,190,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lymphoma AKR (Transplanted) (intraperitoneal) in AKR/Lw mice,Other,,
86,192,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
87,194,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
88,196,1,1,,87150,2907,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intracerebral) in B6D2F1 (BDF1) mice,Other,,
89,198,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in C57BL/6 mice,Other,,
90,200,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in B6C3F1 mice,Other,,
91,206,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  HT29;CX-1 Human Adenocarcinoma (MER+) (intrarenal inoculation) in NU/NU Swiss (nude) mice,Other,,
92,208,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  HT29;CX-1 Human Adenocarcinoma (MER+) (intrarenal inoculation) in NU/NU BALB/C (nude) mice,Other,,
93,210,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Colon 26 Adenocarcinoma (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
94,214,1,1,,87150,2907,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Colon Carcinoma 38 (subcutaneous) in B6C3F1 mice,Other,,
95,216,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P288 Lymphocytic Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
96,220,1,1,,87150,2907,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Mammary Adenocarcinoma CD8F1 (subcutaneous) in CD8F1,Other,,
97,224,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P335 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
98,226,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Ependymoblastoma (intracerebral) in B6C3F1 mice,Other,,
99,228,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Friend Virus Leukemia (Solid) (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
100,230,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lymphosarcoma Gardner 6C3HED (intraperitoneal) in C3H/He mice,Other,,
101,232,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lymphosarcoma Gardner 6C3HED (intraperitoneal) in C3AKF1 (CHKRF1) mice,Other,,
102,236,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  AK4 Lymphoid Leukemia (intraperitoneal) in C3AKF1 (CHKRF1) mice,Other,,
103,246,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P1081 Chloroleukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
104,248,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
105,250,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
106,252,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intracerebral) in B6D2F1 (BDF1) mice,Other,,
107,254,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intravenous) in B6D2F1 (BDF1) mice,Other,,
108,256,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
109,256,1,1,,141705,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
110,256,1,1,,141706,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
111,258,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (subcutaneous) in CD2F1 (CDF1) mice,Other,,
112,260,1,1,,87150,2907,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intracerebral) in CD2F1 (CDF1) mice,Other,,
113,264,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Lung LX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice,Other,,
114,266,1,1,,87150,2907,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Lung LX-1 Xenograft (intrarenal inoculation) in NU/NU BALB/C (nude) mice,Other,,
115,270,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
116,272,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (intramuscular) in B6D2F1 (BDF1) mice,Other,,
117,274,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (intravenous) in B6D2F1 (BDF1) mice,Other,,
118,276,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (intravenous) in B6C3F1 mice,Other,,
119,278,1,1,,87150,2907,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  A549 Human Adenocarcinoma of Lung with characteristics of Type II Alveolar Epithelial cells (intrarenal inoculation) in NU/NU BALB/C (nude) mice,Other,,
120,280,1,1,,87150,2907,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Amelanotic Melanoma (LOX) (intraperitoneal) in NU/NU BALB/C (nude) mice,Other,,
121,282,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia resistant to A Terephthalanilide; NSC 38280 (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
122,284,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia resistant to Methotrexate; NSC 740 (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
123,286,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Sarcoma M5076 (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
124,288,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Sarcoma M5076 (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
125,290,1,1,,87150,2907,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P1798 Lymphosarcoma (subcutaneous) in unknown mice,Other,,
126,292,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Sarcoma M5076 (intraperitoneal) in B6C3F1 mice,Other,,
127,296,1,1,,87150,2907,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Mammary Carcinoma MX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice,Other,,
128,298,1,1,,87150,2907,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Mammary Carcinoma MX-1 Xenograft (intrarenal inoculation) in NU/NU BALB/C (nude) mice,Other,,
129,306,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia resistant to Methyl-GAG; NSC 32946 (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
130,308,1,1,,87150,2907,Active,,,,,"NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia resistant to 6-MP and 6-Thioguanine; NSC 755, NSC 752 (intraperitoneal) in B6D2F1 (BDF1) mice",Other,,
131,310,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Osteogenic Sarcoma HE 10734 (subcutaneous) in C3AKF1 (CHKRF1) mice,Other,,
132,312,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  C1498 Myeloid Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
133,316,1,1,,87150,2907,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P1534 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
134,320,1,1,,87150,2907,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P329 Reticulum Cell Sarcoma (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
135,322,1,1,,87150,2907,Active,,,,,"NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia resistant to Adriamycin; NSC 123127, Developed at Scr 08 (intraperitoneal) in CD2F1 (CDF1) mice",Other,,
136,324,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia resistant to AMSA; NSC 249992 (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
137,326,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia resistant to Dihydroxy Anthracenedione; NSC 299195 (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
138,328,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
139,330,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
140,332,1,1,,87150,2907,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  ADJ-PC-20 Plasma Cell (subcutaneous) in unknown mice,Other,,
141,334,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intracerebral) in CD2F1 (CDF1) mice,Other,,
142,336,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia resistant to Vincristine; NSC 67574 (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
143,338,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia resistant to A Terephthalanilide; NSC 38280 (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
144,340,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Reticulum Cell Sarcoma (Kelley Mouse) (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
145,342,1,1,,87150,2907,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Sarcoma 180 (subcutaneous) in Swiss mice,Other,,
146,344,1,1,,87150,2907,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lieberman Plasma Cell No. 1 (LPC-1) (intraperitoneal) in unknown mice,Other,,
147,357,2,1,,11110909,2907,Inactive,,,,,AP1 Signaling Pathway,Confirmatory,,
148,410,1,5,,11110909,2907,Inactive,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
149,411,2,1,,11110909,2907,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
150,422,1,5,,17404801,2907,Inactive,21464101.0,7532.0,,,HTS for 14-3-3 protein interaction modulators,Screening,,
151,429,1,5,,17404801,2907,Inactive,4261762.0,3326.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
152,429,1,5,,17404801,2907,Inactive,154146191.0,3320.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
153,436,2,1,,17404801,2907,Inactive,68565074.0,8314.0,,,HTS for BAP1 Enzyme inhibitors,Screening,,
154,444,1,1,,11110909,2907,Inactive,,,,,NFAT Signaling Pathway,Confirmatory,,
155,445,3,1,,11110909,2907,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
156,446,1,1,,11110909,2907,Inconclusive,,,,,Stat Signaling Pathway,Confirmatory,,
157,447,1,1,,11110909,2907,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
158,448,1,2,,11110909,2907,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
159,450,1,2,,11110909,2907,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
160,451,1,2,,11110909,2907,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
161,526,1,1,,11110909,2907,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
162,530,1,1,,11110909,2907,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
163,547,1,4,,17404801,2907,Inactive,16130533.0,947097.0,,,HTS for inhibitors of bacterial DnaK,Other,,
164,584,1,3,,11110909,2907,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
165,585,1,4,,11110909,2907,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
166,587,1,5,,11110909,2907,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
167,588,1,4,,11110909,2907,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
168,589,1,3,,11110909,2907,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
169,590,1,3,,11110909,2907,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
170,591,1,4,,11110909,2907,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
171,592,1,6,,11110909,2907,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
172,593,1,4,,11110909,2907,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
173,594,1,4,,11110909,2907,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
174,595,1,3,,11110909,2907,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
175,596,1,2,,11110909,2907,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
176,597,1,3,,11110909,2907,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
177,603,1,2,,11110909,2907,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
178,605,1,2,,11110909,2907,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
179,607,1,3,,11110909,2907,Inactive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
180,662,1,1,,11110909,2907,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
181,694,1,1,,17404801,2907,Inactive,118764400.0,2099.0,,,HTS of LOPAC library for Estrogen Receptor-alpha Coactivator Binding inhibitors,Confirmatory,,
182,732,1,2,,17404801,2907,Inactive,,,,,In Vivo Angiogenesis Assay for HTS,Screening,,
183,880,2,1,,50105634,2907,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
184,880,2,1,,50105634,2907,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
185,883,1,3,,11110909,2907,Inactive,13699818.0,1559.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
186,886,1,2,,11110909,2907,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
187,886,1,2,,11110909,2907,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
188,891,1,2,,11110909,2907,Inactive,40805836.0,1565.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
189,894,2,1,,50105634,2907,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
190,899,1,2,,11110909,2907,Inactive,4503219.0,1557.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
191,912,1,2,,11110909,2907,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
192,914,1,3,,11110909,2907,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
193,915,1,3,,11110909,2907,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
194,925,1,2,,11110909,2907,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
195,926,1,2,,11110909,2907,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
196,938,1,2,,11110909,2907,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
197,940,1,2,,17404801,2907,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
198,1030,2,1,,50105634,2907,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
199,1189,1,5,,48413505,2907,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results,Other,,
200,1190,1,3,,48413505,2907,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Dog & Primates Bioassay Results,Other,,
201,1194,1,3,,48413505,2907,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity,Other,,
202,1195,1,2,,48415829,2907,Active,,,,,DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database,Other,,
203,1199,1,3,,48413505,2907,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Mouse Bioassay Results,Other,,
204,1205,1,4,,48413505,2907,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results,Other,,
205,1208,1,3,,48413505,2907,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results,Other,,
206,1379,1,2,,50105634,2907,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
207,1422,1,1,,17404801,2907,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
208,1454,1,1,,50105634,2907,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
209,1457,1,1,,50105634,2907,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
210,1458,1,1,,50105634,2907,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
211,1459,1,1,,50105634,2907,Inactive,27436948.0,4000.0,,Potency,Validation of Assay for Modulators of Lamin A Splicing,Confirmatory,,
212,1460,1,3,,50105634,2907,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
213,1461,1,2,,50105634,2907,Inconclusive,46395496.0,387129.0,3.9811,Potency,qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction,Confirmatory,,
214,1463,1,1,,50105634,2907,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
215,1467,1,3,,50105634,2907,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
216,1468,1,1,,50105634,2907,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
217,1469,1,1,,50105634,2907,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
218,1471,2,1,,11110909,2907,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
219,1476,2,1,,50105634,2907,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
220,1477,1,1,,50105634,2907,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
221,1478,2,1,,50105634,2907,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
222,1479,1,2,,50105634,2907,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
223,1487,1,1,,50105634,2907,Inactive,27436948.0,4000.0,,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
224,1519,1,3,,50105634,2907,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
225,1705,1,2,,50105634,2907,Inactive,6980812.0,,,Potency,qHTS Validation Assay for Inhibitors of the Human Apurinic/apyrimidinic  Endonuclease 1 (APE1),Confirmatory,,
226,1707,1,3,,50105634,2907,Inactive,,,,Potency,Counterscreen for APE1 Inhibitors: Fluorescent Dye Displacement Validation Assay,Confirmatory,,
227,1708,1,3,,50105634,2907,Inactive,405898.0,,,Potency,Counterscreen for APE1 Inhibitors: qHTS Validation Assay for Inhibitors of Endonuclease IV,Confirmatory,,
228,1766,1,1,,50105634,2907,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
229,1766,1,1,,50105634,2907,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
230,1768,1,1,,50105634,2907,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
231,1768,1,1,,50105634,2907,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
232,1815,1,1,,50105634,2907,Inactive,,,,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8,Confirmatory,,
233,1816,1,1,,50105634,2907,Inactive,,,,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4,Confirmatory,,
234,1828,2,1,,50105634,2907,Inactive,,,,,qHTS for Inhibitors of Plasmodium falciparum proliferation: Summary,Summary,,
235,1865,1,1,,50105634,2907,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
236,1876,1,1,,50105634,2907,Inactive,,,,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7,Confirmatory,,
237,1877,1,1,,50105634,2907,Inactive,,,,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10,Confirmatory,,
238,1882,1,1,,50105634,2907,Inactive,,,,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2,Confirmatory,,
239,1883,1,1,,50105634,2907,Inactive,,,,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2,Confirmatory,,
240,1886,1,1,,50105634,2907,Inactive,,,,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3,Confirmatory,,
241,1948,1,1,,50105634,2907,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
242,1967,1,1,,85230959,2907,Inactive,4505907.0,5376.0,,Potency,qHTS Assay for Modulators of Human Peripheral Myelin Protein 22 (PMP22) Expression/Activity,Confirmatory,,
243,2101,1,1,,50105634,2907,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
244,2107,1,1,,50105634,2907,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
245,2112,1,1,,50105634,2907,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
246,2147,1,1,,50105634,2907,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
247,2323,1,1,,50105634,2907,Inactive,254220970.0,,,Potency,qHTS Validation Assay for Identification of Novel General Anesthetics,Confirmatory,,
248,2326,1,1,,50105634,2907,Inactive,194352380.0,,,Potency,qHTS Assay for Inhibitors of Influenza NS1 Protein Function,Confirmatory,,
249,2353,1,3,,50105634,2907,Inactive,282403581.0,,,Potency,qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
250,2364,1,2,,50105634,2907,Inactive,4557365.0,641.0,,Potency,qHTS Validation Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
251,2451,1,2,,50105634,2907,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
252,2517,2,1,,50105634,2907,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
253,2528,1,2,,50105634,2907,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
254,2549,1,1,,50105634,2907,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
255,2660,1,1,,90341534,2907,Inactive,4826730.0,2475.0,,Potency,"Cytometric Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
256,2662,2,1,,85230959,2907,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
257,2666,1,1,,90341534,2907,Inactive,4826730.0,2475.0,,Potency,"High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
258,2667,1,1,,90341534,2907,Inactive,4826730.0,2475.0,,Potency,High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF Cells,Confirmatory,,
259,2668,1,1,,90341534,2907,Inactive,4826730.0,2475.0,,Potency,Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells,Confirmatory,,
260,2675,1,1,,50105634,2907,Unspecified,41281591.0,4154.0,,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding,Confirmatory,,
261,2732,1,1,,17404801,2907,Inactive,160707929.0,13198.0,,,HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress,Screening,,
262,2774,1,3,,92303457,2907,Inactive,,,,,LOPAC Circadian Assay,Screening,,
263,3372,7,3,,103171472,2907,Active,,,37.6,LC50,In vitro cytotoxicity was evaluated in mouse embryo BALB/c 3T3 cells,Confirmatory,9873412.0,
264,10061,4,4,,103171472,2907,Unspecified,,,,,"Compound was tested for dose producing 90% reduction in tumor weight, in ADJ/PC6 mouse plasma cell tumor",Other,7310816.0,
265,10063,7,2,,103171472,2907,Unspecified,,,,,Compound was tested for dose required to kill 50 % of ADJ/PC6 mouse plasma cell tumor in a group,Other,7310816.0,
266,19006,4,3,,103171472,2907,Unspecified,,,,,Calculated membrane partition coefficient (Kmemb),Other,15027870.0,
267,22293,4,4,,103171472,2907,Unspecified,,,,,Delta logD (logD6.5 - logD7.4),Other,10891117.0,
268,23271,4,4,,103171472,2907,Unspecified,,,,,Partition coefficient (logD7.4),Other,2362268.0,
269,24064,5,2,,103171472,2907,Unspecified,,,,,The half life at a pH 1.2,Other,7966159.0,
270,24065,5,2,,103171472,2907,Unspecified,,,,,The half life at a physiological pH,Other,7966159.0,
271,26304,4,4,,103171472,2907,Unspecified,,,,,Partition coefficient (logD6.5),Other,10891117.0,
272,29360,4,3,,103171472,2907,Inconclusive,,,,,Ionization constant (pKa),Other,10891117.0,
273,29811,4,3,,103171472,2907,Unspecified,,,,,Oral bioavailability in human,Other,10891117.0,
274,39592,4,4,,103171472,2907,Unspecified,,,,,"Compound was evaluated for the antineoplastic activity on B16 Melanoma cells at the optimal dose of 100 mg/kg through intraperitoneal route on days 1,5,9",Other,4067995.0,
275,39594,4,4,,103171472,2907,Unspecified,,,,,"Compound was evaluated for the antineoplastic activity on B16 Melanoma cells at the optimal dose of 120 mg/kg through intraperitoneal route on days 1,5,9",Other,4067995.0,
276,39715,3,4,,103171472,2907,Unspecified,,,,,"Compound was evaluated for the antineoplastic activity on B16 Melanoma cells at the optimal dose of 70 mg/kg through intraperitoneal route on days 1,5,9",Other,4067995.0,
277,41067,3,4,,103171472,2907,Unspecified,,,,,Effect on metastases of B16F10.9 melanoma cells (intraperitoneally implanted) in B6C3F1/OLAC/HSD mice was observed after administration of 50 mg/kg dose,Other,1542095.0,
278,41072,3,4,,103171472,2907,Unspecified,,,,,Effect on metastases of B16F10.9 melanoma cells (intraperitoneally implanted) in B6C3F1/OLAC/HSD mice was observed after administration of 50 mg/kg dose,Other,1542095.0,
279,41567,6,3,,103171472,2907,Active,,,37.6,IC50,In vitro cytotoxicity against BALB/c 3T3 cells,Confirmatory,7877150.0,
280,41575,7,2,,103171472,2907,Active,,,37.6,LC50,In vitro cytotoxicity in BALB/c3T3 mouse embryo fibroblasts.,Confirmatory,1995881.0,
281,43047,3,4,,103171472,2907,Unspecified,,,,,"Antitumor activity against C26 implants through intraperitoneal route along with the optimal dose of 125 mg/kg through intraperitoneal injection on 1,4 days",Other,4067995.0,
282,43166,3,5,,103171472,2907,Unspecified,,,,,"Antitumor activity against C26 implants through subcutaneous route along with the optimal dose of 125 mg/kg through intraperitoneal injection on 1,4 days",Other,4067995.0,
283,45742,3,4,,103171472,2907,Unspecified,,,,,Effect on collateral sensitivity of CHRC5 cells to local anesthetics/steroids.,Other,2362268.0,
284,93938,6,2,,103171472,2907,Unspecified,,,300.0,IC50,Concentration required to reduce the viability of L1210 cells by 50% after 1-h incubation at 37 degrees C,Confirmatory,1992116.0,
285,94249,3,5,,103171472,2907,Unspecified,,,,,In vivo antitumor activity against intraperitoneal murine cyclophosphamide resistant L1210 Leukemia cells at 170 umol/kg,Other,1920355.0,
286,94250,3,5,,103171472,2907,Unspecified,,,,,In vivo antitumor activity against intraperitoneal murine cyclophosphamide resistant L1210 Leukemia cells at 510 umol/kg,Other,1920355.0,
287,94253,5,3,,103171472,2907,Unspecified,,,,,In vivo antitumor activity against intraperitoneal murine cyclophosphamide resistant L1210 Leukemia cells at 680 umol/kg; Toxic,Other,1920355.0,
288,94254,3,5,,103171472,2907,Unspecified,,,,,In vivo antitumor activity against intraperitoneal murine cyclophosphamide resistant L1210 Leukemia cells at 340 umol/kg,Other,1920355.0,
289,94255,3,5,,103171472,2907,Unspecified,,,,,In vivo antitumor activity against intraperitoneal murine wild type L1210 Leukemia cells at 170 umol/kg,Other,1920355.0,
290,94256,3,5,,103171472,2907,Unspecified,,,,,In vivo antitumor activity against intraperitoneal murine wild type L1210 Leukemia cells at 340 umol/kg,Other,1920355.0,
291,94257,3,5,,103171472,2907,Unspecified,,,,,In vivo antitumor activity against intraperitoneal murine wild type L1210 Leukemia cells at 510 umol/kg,Other,1920355.0,
292,94260,5,4,,103171472,2907,Unspecified,,,,,In vivo antitumor activity against intraperitoneal murine wild type L1210 Leukemia cells at 680 umol/kg,Other,1920355.0,
293,98670,5,2,,103171472,2907,Inactive,,,,,Compound was tested in vitro for its inhibition against replication of L1210 neoplastic cells; Inactive,Other,7452673.0,
294,108234,3,3,,103171472,2907,Unspecified,,,,,Drug related lethality is percent animals in treated groups dying prior to first tumor related death in untreated groups measured in BDF1 mice after ip administration at 300 mg/kg dose days 3 after tumor challenge,Other,2002471.0,
295,108237,3,3,,103171472,2907,Unspecified,,,,,Drug related lethality is percent animals in treated groups dying prior to first tumor related death in untreated groups measured in BDF1 mice after ip administration at 400 mg/kg dose days 3 after tumor challenge,Other,2002471.0,
296,108398,3,3,,103171472,2907,Unspecified,,,,,"In vivo activity was measured against 3LL metastasis in BDF1 mice after ip administration at 300 mg/kg dose, dosing on days 3 after tumor challenge",Other,2002471.0,
297,108399,3,3,,103171472,2907,Unspecified,,,,,"In vivo activity was measured against 3LL metastasis in BDF1 mice after ip administration at 400 mg/kg dose, dosing on days 3 after tumor challenge",Other,2002471.0,
298,108686,3,3,,103171472,2907,Unspecified,,,,,Average weight change on day 5 in mice infected by P-388 leukemia when treated with a dose of 125 mg/Kg of compound,Other,3373492.0,
299,108690,3,3,,103171472,2907,Unspecified,,,,,Average weight change on day 5 in mice infected by P-388 leukemia when treated with a dose of 250 mg/Kg of compound,Other,3373492.0,
300,112596,3,4,,103171472,2907,Unspecified,,,,,Percent increase in life span of mice bearing L1210 ascites cells compared to control; Administered alone and concurrently with the preceding compounds onday 1 at a dose of 100 mg/kg (in vivo),Other,7365745.0,
301,115179,3,4,,103171472,2907,Unspecified,,,,,Percentage increased life span against L1210 leukemia cells in mice;(1.08 mmol/kg dosage),Other,7877150.0,
302,115424,6,1,,103171472,2907,Unspecified,,,,,"Compound was administered to non-tumor bearing female CDF1 mice in,Mean corpuscular hemoglobin concentration (MCHC)",Other,10780911.0,
303,115638,3,3,,103171472,2907,Unspecified,,,,,Antitumor activity was tested in mice and percent increase of life span at a dose of 125 ug/kg was reported,Other,10780911.0,
304,116273,3,3,,103171472,2907,Unspecified,,,,,Increase in life span of mice bearing L1210 leukemia after administration of 25 mg compound,Other,12570384.0,
305,116289,4,5,,103171472,2907,Unspecified,,,,,Increased life span against L1210 lymphoid leukemia cells in male BDF1 mice at a dose of 100 mg/kg,Other,3701785.0,
306,116290,3,5,,103171472,2907,Unspecified,,,,,Increased life span against L1210 lymphoid leukemia cells in male BDF1 mice at a dose of 100x1 mg/kg,Other,3701785.0,
307,116293,5,1,,103171472,2907,Unspecified,,,,,Increased life span against L1210 lymphoid leukemia cells in male BDF1 mice at a dose of 200 mg/kg,Other,3701785.0,
308,116307,3,3,,103171472,2907,Unspecified,,,,,Maximum life span of mice after 100 mg/kg ip administration; Increases range 75-100,Other,7310817.0,
309,116414,3,3,,103171472,2907,Unspecified,,,,,Maximum life span of mice after 200 mg/kg ip administration; Increases range 150-200,Other,7310817.0,
310,117642,3,4,,103171472,2907,Inactive,,,,,In vivo activity against transplanted Mam-16/C/ Taxol tumors of mice; Not active,Other,11356111.0,
311,117730,3,4,,103171472,2907,Unspecified,,,,,Percent reduction in spleen weight in mice as compared to infected untreated controls at 25 mg/kg,Other,6644739.0,
312,118370,3,3,,103171472,2907,Unspecified,,,,,"Compound was tested for the ability to suppress humoral immune response in mice treated for days 0,+1,and +2 at dose of 25 mg/kg (control = 7.1)",Other,7265126.0,
313,118957,6,1,,103171472,2907,Unspecified,,,,,Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 120 mg/kg in experiment 2,Other,7057413.0,
314,118958,6,1,,103171472,2907,Unspecified,,,,,Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 150 mg/kg in experiment 3,Other,7057413.0,
315,118967,6,1,,103171472,2907,Unspecified,,,,,Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 300 mg/kg in experiment 3,Other,7057413.0,
316,118968,6,1,,103171472,2907,Unspecified,,,,,Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 37 mg/kg in experiment 3,Other,7057413.0,
317,118976,6,1,,103171472,2907,Unspecified,,,,,Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 75 mg/kg in experiment 3,Other,7057413.0,
318,118980,6,1,,103171472,2907,Unspecified,,,,,Effect of compound on life span of mice inoculated intravenously with lewis lung carcinoma at the dose of 90 mg/kg in experiment 2,Other,7057413.0,
319,119059,9,1,,103171472,2907,Unspecified,,,,,"Hematological effects in female CDF1 mice at the dose of 30 mg, in red blood cells cells",Other,10780911.0,
320,120051,3,3,,103171472,2907,Unspecified,,,,,"Median survival time (MST) of treated mice infected by P-388 leukemia, as percent of the MST of untreated controls when treated with a dose of 125 mg/Kg of compound",Other,3373492.0,
321,120055,3,3,,103171472,2907,Unspecified,,,,,"Median survival time (MST) of treated mice infected by P-388 leukemia, as percent of the MST of untreated controls when treated with a dose of 250 mg/Kg of compound",Other,3373492.0,
322,120159,4,4,,103171472,2907,Unspecified,,,,,Compound was ested for antitumor activity against Lewis lung carcinoma cells implanted in male C57BL mice at a dose of 20 mg/kg,Other,3701785.0,
323,120467,3,5,,103171472,2907,Unspecified,,,,,Number of survivors on day 60 at a dose of 100 x 1 mg/kg; 0/7,Other,3701785.0,
324,120468,3,5,,103171472,2907,Unspecified,,,,,Number of survivors on day 60 at a dose of 100 mg/kg; 0/6,Other,3701785.0,
325,120469,4,5,,103171472,2907,Unspecified,,,,,Number of survivors on day 60 at a dose of 100 mg/kg; 0/7,Other,3701785.0,
326,120470,3,5,,103171472,2907,Unspecified,,,,,Number of survivors on day 60 at a dose of 100 mg/kg; 4/7,Other,3701785.0,
327,120473,3,5,,103171472,2907,Unspecified,,,,,Number of survivors on day 60 at a dose of 200 mg/kg; 4/7,Other,3701785.0,
328,120481,4,5,,103171472,2907,Unspecified,,,,,Number of survivors on the toxicity day (day = 15) at a dose of 100x1 mg/kg,Other,3701785.0,
329,120499,3,4,,103171472,2907,Unspecified,,,,,Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 120 mg/kg in experiment 2,Other,7057413.0,
330,120500,3,4,,103171472,2907,Unspecified,,,,,Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 150 mg/kg in experiment 3,Other,7057413.0,
331,120509,3,4,,103171472,2907,Unspecified,,,,,Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 300 mg/kg in experiment 3,Other,7057413.0,
332,120620,3,4,,103171472,2907,Unspecified,,,,,Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 37 mg/kg in experiment 3,Other,7057413.0,
333,120628,3,4,,103171472,2907,Unspecified,,,,,Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 75 mg/kg in experiment 3,Other,7057413.0,
334,120632,3,4,,103171472,2907,Unspecified,,,,,Number of survivors out of 10 mice after 60 days infected with lewis lung carcinoma at the dose of 90 mg/kg in experiment 2,Other,7057413.0,
335,120817,4,4,,103171472,2907,Unspecified,,,,,Tumor free mice out of 8 surviving to day 60 or beyond was determined,Other,4067995.0,
336,121203,3,4,,103171472,2907,Unspecified,,,,,The compound was tested for the anticancer activity against Lewis lung carcinoma cells implanted in male BALB/c mice at a dose of 100x1 mg/kg,Other,3701785.0,
337,121204,3,4,,103171472,2907,Unspecified,,,,,The compound was tested for the anticancer activity against Lewis lung carcinoma cells implanted in male C57BL mice at a dose of 100x1 mg/kg,Other,3701785.0,
338,121717,3,4,,103171472,2907,Unspecified,,,,,"Number of mice bearing L1210 leukemia that survived after 30 days, after administration of 25 mg compound",Other,12570384.0,
339,121963,3,3,,103171472,2907,Unspecified,,,,,In vivo antitumor activity measured in mice against the Colon26/A murine solid tumors.,Other,9733489.0,
340,121966,3,3,,103171472,2907,Unspecified,,,,,In vivo antitumor activity measured in mice against the Mam16/C murine solid tumors.,Other,9733489.0,
341,121967,3,3,,103171472,2907,Unspecified,,,,,In vivo antitumor activity measured in mice against the Panc 02 murine solid tumors.,Other,9733489.0,
342,123016,3,4,,103171472,2907,Unspecified,,,,,"Antitumor activity in BDF1 male mice bearing L1210 Leukemia, at a dose of 188 mg/kg; survivors for 30 days was reported",Other,10780911.0,
343,123017,3,4,,103171472,2907,Unspecified,,,,,"Antitumor activity in BDF1 male mice bearing L1210 Leukemia, at a dose of 250 mg/kg; survivors for 30 days was reported",Other,10780911.0,
344,123040,3,4,,103171472,2907,Unspecified,,,,,"Antitumor activity in BDF1 male mice bearing L1210 Leukemia, at a dose of 125 mg/kg; survivors for 30 days was reported",Other,10780911.0,
345,123387,8,1,,103171472,2907,Unspecified,,,,,"Hematological effects in female CDF1 mice at the dose of 30 mg, in platelet cells",Other,10780911.0,
346,124033,8,1,,103171472,2907,Unspecified,,,,,"Hematological effects in female CDF1 mice at the dose of 30 mg, in white blood cells",Other,10780911.0,
347,124192,3,4,,103171472,2907,Unspecified,,,,,Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 120 mg/kg in experiment 2,Other,7057413.0,
348,124193,3,4,,103171472,2907,Unspecified,,,,,Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 150 mg/kg in experiment 3,Other,7057413.0,
349,124253,3,3,,103171472,2907,Unspecified,,,,,In vivo activity against iv transplanted AML Leukemia 1498 tumors of mice,Other,11356111.0,
350,124254,3,3,,103171472,2907,Unspecified,,,,,In vivo activity against iv transplanted Leukemia L1210 tumors of mice,Other,11356111.0,
351,124255,3,3,,103171472,2907,Unspecified,,,,,In vivo activity against transplanted Mam-16/C tumors of mice,Other,11356111.0,
352,124257,3,3,,103171472,2907,Unspecified,,,,,In vivo activity against transplanted Mam-16/C/Adr tumors of mice,Other,11356111.0,
353,124259,3,3,,103171472,2907,Unspecified,,,,,In vivo activity against transplanted Mam-17 tumors of mice,Other,11356111.0,
354,124260,3,3,,103171472,2907,Unspecified,,,,,In vivo activity against transplanted Mam-17/Adr tumors of mice,Other,11356111.0,
355,124261,3,3,,103171472,2907,Unspecified,,,,,In vivo activity against transplanted Mel-B16 tumors of mice,Other,11356111.0,
356,124262,3,3,,103171472,2907,Unspecified,,,,,In vivo activity against transplanted Panc-02 tumors of mice,Other,11356111.0,
357,124263,3,3,,103171472,2907,Unspecified,,,,,In vivo activity against transplanted Panc-03 tumors of mice,Other,11356111.0,
358,124264,3,3,,103171472,2907,Unspecified,,,,,In vivo activity against transplanted Squam lung-LC12 tumors of mice,Other,11356111.0,
359,124265,3,3,,103171472,2907,Unspecified,,,,,In vivo activity against transplanted colon-26 tumors of mice,Other,11356111.0,
360,124266,3,3,,103171472,2907,Unspecified,,,,,In vivo activity against transplanted colon-38 tumors of mice,Other,11356111.0,
361,124267,3,3,,103171472,2907,Unspecified,,,,,In vivo activity against transplanted colon-51 tumors of mice,Other,11356111.0,
362,124288,3,4,,103171472,2907,Unspecified,,,,,"Antitumor activity in mice bearing L1210 Leukemia, at a dose of 30 mg/kg at 50 days",Other,10780911.0,
363,124326,3,4,,103171472,2907,Unspecified,,,,,Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 300 mg/kg in experiment 3,Other,7057413.0,
364,124327,3,4,,103171472,2907,Unspecified,,,,,Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 37 mg/kg in experiment 3,Other,7057413.0,
365,124335,3,4,,103171472,2907,Unspecified,,,,,Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 75 mg/kg in experiment 3,Other,7057413.0,
366,124339,3,4,,103171472,2907,Unspecified,,,,,Average body weight in grams on day 5 minus average body weight on day 1 at the dose of 90 mg/kg in experiment 2,Other,7057413.0,
367,124393,3,3,,103171472,2907,Unspecified,,,,,Percent animals surviving 50 days from day 1; Administered alone and concurrently with the preceding compounds onday 1 at a dose of 100 mg/kg (in vivo),Other,7365745.0,
368,124616,4,3,,103171472,2907,Unspecified,,,,,Body weight change between days 0 and the day when the animal weight was the lowest,Other,10780911.0,
369,124972,3,4,,103171472,2907,Unspecified,,,,,Weight change in mice bearing L1210 leukemia after administration of 25 mg compound,Other,12570384.0,
370,128513,2,4,,103171472,2907,Unspecified,,,,,Tested in vivo for immunosuppressive activity in mouse using graft vs. Host rejection technique (GVHR); % suppression at a dose of 200 mg/kg,Other,,
371,129214,2,4,,103171472,2907,Unspecified,,,,,Tested in vivo for immunosuppressive activity in mouse using graft vs. Host rejection technique (GVHR); body weight at a dose of 200 mg/kg,Other,,
372,130307,3,3,,103171472,2907,Unspecified,,,,,Percentage increase in life span of L1210 leukemia implanted mice at a dose of 120 mg/kg,Other,3336021.0,
373,130309,4,3,,103171472,2907,Unspecified,,,,,Percentage increase in life span of L1210 leukemia implanted mice at a dose of 150 mg/kg,Other,3336021.0,
374,130311,4,3,,103171472,2907,Unspecified,,,,,Percentage increase in life span of L1210 leukemia implanted mice at a dose of 200 mg/kg,Other,3336021.0,
375,130314,4,3,,103171472,2907,Unspecified,,,,,Percentage increase in life span of L1210 leukemia implanted mice at a dose of 300 mg/kg,Other,3336021.0,
376,130315,4,3,,103171472,2907,Unspecified,,,,,Percentage increase in life span of L1210 leukemia implanted mice at a dose of 400 mg/kg,Other,3336021.0,
377,132249,7,2,,103171472,2907,Unspecified,,,,,Effective dose that causes 50% increase in life span of mice,Other,3336021.0,
378,134603,6,2,,103171472,2907,Unspecified,,,,,Lethal dose was evaluated after single intraperitoneal injection in mice,Other,7966159.0,
379,134723,7,2,,103171472,2907,Unspecified,,,,,Lethal dose to kill 50% of the mice after single ip injection to healthy female CD2F1 mice,Other,3336021.0,
380,135324,3,3,,103171472,2907,Unspecified,,,,,Evaluated for the delayed type hypersensitivity (DTH) response to methylated BSA (mBSA) in sensitive mice after peroral administration of 50 mg/kg,Other,2115585.0,
381,135944,5,3,,103171472,2907,Unspecified,,,,,Number of mice that survived on day 60 at a dose of 120 mg/kg; 1/12,Other,3336021.0,
382,135946,5,3,,103171472,2907,Unspecified,,,,,Number of mice that survived on day 60 at a dose of 150 mg/kg; 1/19,Other,3336021.0,
383,135957,5,3,,103171472,2907,Unspecified,,,,,Number of mice that survived on day 60 at a dose of 200 mg/kg; 8/12,Other,3336021.0,
384,135961,5,3,,103171472,2907,Unspecified,,,,,Number of mice that survived on day 60 at a dose of 300 mg/kg; 16/18,Other,3336021.0,
385,135967,5,3,,103171472,2907,Unspecified,,,,,Number of mice that survived on day 60 at a dose of 400 mg/kg; 7/18,Other,3336021.0,
386,137593,2,5,,103171472,2907,Unspecified,,,,,Tested in vivo for immunosuppressive activity in mouse using graft vs. Host rejection technique (GVHR); spleen index at a dose of 200 mg/kg,Other,,
387,137760,2,5,,103171472,2907,Unspecified,,,,,Tested in vivo for immunosuppressive activity in mouse using graft vs. Host rejection technique (GVHR); spleen weight normalized to D8 body weight at a dose of 200 mg/kg,Other,,
388,137949,3,3,,103171472,2907,Unspecified,,,,,Immunological activity in mice as the percentage of suppression of the cellular response to EI4 tumor cells at 10 mg/kg,Other,7277388.0,
389,137950,3,3,,103171472,2907,Unspecified,,,,,"Compound was evaluated for immunological activity in mice as the percentage of suppression of the humoral response to EI4 tumor cells at 10 mg/kg, po",Other,7277388.0,
390,139024,2,5,,103171472,2907,Unspecified,,,,,Tested in vivo for immunosuppressive activity in mouse using graft vs. Host rejection technique (GVHR); weight change at a dose of 200 mg/kg,Other,,
391,188467,3,3,,103171472,2907,Unspecified,,,,,Evaluated for effect against passive cutaneous anaphylaxis in rats immunized with DNP-As and B. pertussis; PCA (log2),Other,7154011.0,
392,189454,3,3,,103171472,2907,Unspecified,,,,,Evaluated for effect against passive hemagglutinination in rats immunized with DNP-As and B. pertussis; PHA(log2),Other,7154011.0,
393,194084,3,3,,103171472,2907,Unspecified,,,,,Antiinflammatory activity against D-adjuvant arthiritis in injected rat paw at the dose of 25 mg/kg by oral administration,Other,1732553.0,
394,194090,3,3,,103171472,2907,Unspecified,,,,,Antiinflammatory activity against D-adjuvant arthiritis in uninjected rat paw at the dose of 25 mg/kg by oral administration,Other,1732553.0,
395,197087,4,3,,103171472,2907,Unspecified,,,,,Alkylating activity determined by incubating with rat hepatic microsomes and time dependent release of alkylating species with no pretreatment; Activity expressed as uM of mechlorethamine equiv/g of liver/h,Other,1995881.0,
396,197088,4,3,,103171472,2907,Unspecified,,,,,Alkylating activity determined by incubating with rat hepatic microsomes and time dependent release of alkylating species with phenobarbital pretreatment; Activity expressed as uM of mechlorethamine equiv/g of liver/h,Other,1995881.0,
397,197089,3,3,,103171472,2907,Unspecified,,,,,Percent decrease in the microsomal activation determined with no pretreatment,Other,1995881.0,
398,197091,3,3,,103171472,2907,Unspecified,,,,,Percent decrease in the microsomal activation determined with pretreatment with phenobarbital.,Other,1995881.0,
399,201895,6,1,,103171472,2907,Unspecified,,,,,"Ability of compound (220 mg/kg, single dose) to inhibit growth of Sc colon 38 tumor cells in mice",Other,2704025.0,
400,223907,4,3,,103171472,2907,Unspecified,,,,,Antiinflammatory activity dosed orally against D-adjuvant arthiritis in rat.,Other,1732553.0,
401,225628,4,3,,103171472,2907,Unspecified,,,,,Antiinflammatory activity dosed orally against carrageenan induced rat paw edema(CPE),Other,1732553.0,
402,235611,4,3,,103171472,2907,Unspecified,,,,,Therapeutic index as the ratio of LD50 to ED50 of the compound,Other,7310816.0,
403,249473,3,3,,103171472,2907,Unspecified,,,,,"Effect (10 mg/kg/day*7 days, i.v.) on cyclophosphamide (CY, i.p.) treated mice (immunosuppressed animal model) assessed by CD4+/CD8+ ratio in peripheral blood mononuclear cells",Other,16078831.0,
404,268526,4,3,,103171472,2907,Unspecified,,,,,"Antitumor activity against S180 cells implanted in mouse at 30 mg/kg, ip",Other,16682187.0,
405,268527,3,4,,103171472,2907,Unspecified,,,,,"Antitumor activity against H22 cells implanted in mouse at 30 mg/kg, ip",Other,16682187.0,
406,268532,6,2,,103171472,2907,Unspecified,,,,,Toxicity in ip dosed mouse,Other,16682187.0,
407,287254,3,4,,103171472,2907,Unspecified,,,,,"Antitumor activity against S180 cells inoculated in ICR mouse assessed as tumor weight at 50 mg/kg, ip after 8 days",Other,17137679.0,
408,287256,3,4,,103171472,2907,Unspecified,,,,,"Antitumor activity against S180 cells inoculated in ICR mouse assessed as inhibition at 50 mg/kg, ip after 8 days relative to control",Other,17137679.0,
409,304762,3,5,,103171472,2907,Unspecified,,,,,"Antitumor activity against LLC cells inoculated in C57BL/6J mouse assessed as lung weight at 100 mg/kg, ip administered alternatively for 12 days",Other,18052315.0,
410,306338,3,4,,103171472,2907,Unspecified,,,,,"Antitumor activity in H22 cells xenografted ICR mouse assessed as tumor weight at 30 mg/kg, iv after 4 days",Other,17275295.0,
411,306339,3,4,,103171472,2907,Unspecified,,,,,"Antitumor activity in H22 cells xenografted ICR mouse assessed as tumor growth inhibition at 30 mg/kg, iv after 4 days",Other,17275295.0,
412,311524,4,3,,103171472,2907,Unspecified,,,,,Oral bioavailability in human,Other,17870541.0,
413,318174,3,4,,103171472,2907,Unspecified,,,,,"Effect on body weight in mouse bearing S180 cells at 30 mg/kg/day, ip after 10 days",Other,18226907.0,
414,318176,3,4,,103171472,2907,Unspecified,,,,,"Antitumor activity in mouse xenografted with S180 cells assessed as inhibition of tumor growth at 30 mg/kg/day, ip after 10 days",Other,18226907.0,
415,318178,3,4,,103171472,2907,Unspecified,,,,,"Effect on body weight in mouse bearing H22 cells at 30 mg/kg/day, ip after 10 days",Other,18226907.0,
416,318181,3,4,,103171472,2907,Unspecified,,,,,"Antitumor activity in mouse xenografted with H22 cells assessed as inhibition of tumor growth at 30 mg/kg/day, ip after 10 days",Other,18226907.0,
417,348245,3,4,,103171472,2907,Unspecified,,,,,"Antitumor activity against human MX1 cells xenografted in SCID mouse assessed as tumor volume at 12.5 mg/kg/day, ip after 34 days",Other,19143569.0,
418,348246,4,1,,103171472,2907,Unspecified,,,,,"Antitumor activity against human MX1 cells xenografted in SCID mouse assessed as growth inhibition at 12.5 mg/kg/day, ip after 34 days relative to control",Other,19143569.0,
419,348247,3,4,,103171472,2907,Unspecified,,,,,"Antitumor activity against human MX1 cells xenografted in SCID mouse assessed as tumor volume at 12.5 mg/kg/day, ip after 48 days",Other,19143569.0,
420,366671,3,4,,103171472,2907,Unspecified,,,,,"Antitumor activity in mouse H22 cell xenografted mouse at 20 mg/kg/day, iv after 4 days",Other,18644718.0,
421,386623,4,8,,103171472,2907,Unspecified,313104181.0,6580.0,,,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells at 100 uM by confocal microscopy,Other,18788725.0,
422,408369,3,4,,103171472,2907,Active,,,,,"Antitumor activity in human U87 MG cells xenografted mouse at 80 mg/kg, iv administered in Q2D x 5 schedule",Other,18450456.0,
423,408371,3,4,,103171472,2907,Unspecified,,,,,"Toxicity against human U87 MG cells xenografted mouse assessed as body weight loss at 80 mg/kg, iv administered in Q2D x 5 schedule",Other,18450456.0,
424,408575,3,3,,103171472,2907,Unspecified,,,,,Effect on DNA cleavage in ampicillin resistant Escherichia coli DH5alpha transformed pBluescript 2 KS+ DNA assessed as number of colonies at 10 mM after 15 hrs by transformation assay,Other,18434165.0,
425,408577,3,3,,103171472,2907,Active,,,,,Induction of Escherichia coli pBluescript 2 KS+ DNA cleavage at 10 mM by gel electrophoresis,Other,18434165.0,
426,409954,4,9,,103171472,2907,Inactive,341940599.0,17161.0,,,Inhibition of mouse brain MAOA,Other,18834112.0,
427,409955,3,9,,103171472,2907,Inactive,341940629.0,109731.0,,,Inhibition of mouse liver MAOB,Other,18834112.0,
428,409956,4,9,,103171472,2907,Inactive,341940629.0,109731.0,,,Inhibition of mouse brain MAOB,Other,18834112.0,
429,409958,3,9,,103171472,2907,Inactive,124028637.0,281293.0,,,Inhibition of bovine brain MAOA,Other,18834112.0,
430,409960,3,9,,103171472,2907,Inactive,124028638.0,338445.0,,,Inhibition of bovine brain MAOB,Other,18834112.0,
431,425652,7,2,,103171472,2907,Unspecified,,,,,Total body clearance in human,Other,19445515.0,
432,425653,7,2,,103171472,2907,Unspecified,,,,,Renal clearance in human,Other,19445515.0,
433,444050,7,1,,103171472,2907,Unspecified,,,,,Fraction unbound in human plasma,Other,20070106.0,
434,444051,6,2,,103171472,2907,Unspecified,,,,,Total clearance in human,Other,20070106.0,
435,444052,6,2,,103171472,2907,Unspecified,,,,,Hepatic clearance in human,Other,20070106.0,
436,444053,6,2,,103171472,2907,Unspecified,,,,,Renal clearance in human,Other,20070106.0,
437,444054,6,1,,103171472,2907,Unspecified,,,,,Oral bioavailability in human,Other,20070106.0,
438,444055,3,3,,103171472,2907,Unspecified,,,,,Fraction absorbed in human,Other,20070106.0,
439,444056,3,3,,103171472,2907,Unspecified,,,,,Fraction escaping gut-wall elimination in human,Other,20070106.0,
440,444057,3,3,,103171472,2907,Unspecified,,,,,Fraction escaping hepatic elimination in human,Other,20070106.0,
441,444058,6,2,,103171472,2907,Unspecified,,,,,Volume of distribution at steady state in human,Other,20070106.0,
442,463096,1,1,,50105634,2907,Inactive,,,,Potency,Validation screen for inhibitors of Lassa infection,Confirmatory,,
443,463097,1,1,,50105634,2907,Inactive,7705682.0,51053.0,,Potency,Validation screen for small molecules that induce DNA re-replication in MCF 10A normal breast cells,Confirmatory,,
444,463106,1,2,,90341534,2907,Inactive,188528692.0,9099.0,,Potency,qHTS Validation Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
445,463189,1,1,,53777344,2907,Inactive,,,,,96-well format Chlamydomonas reinhardtii Algae Gravitaxis Assay to measure the difference in the absorbance between the small compact plug of WT swimming algae versus the MUT algae lacking cilia.,Screening,,
446,477295,3,3,,103171472,2907,Unspecified,,,,,"Octanol-water partition coefficient, log P of the compound",Other,20106561.0,
447,481567,3,4,,103171472,2907,Unspecified,,,,,"Antitumor activity against mouse S180 cells xenografted in ICR mouse assessed as reduction of tumor weight at 100 mg/kg, ig administered 2 days after tumor inoculation qd for 7 days",Other,20403695.0,
448,481569,4,4,,103171472,2907,Unspecified,,,,,"Antitumor activity against mouse S180 cells xenografted in ICR mouse assessed as inhibition of tumor weight at 100 mg/kg, ig administered 2 days after tumor inoculation qd for 7 days relative to control",Other,20403695.0,
449,485290,1,1,,50105634,2907,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
450,485295,1,2,,90341534,2907,Inactive,30027657.0,,,Potency,qHTS Validation Assay for the Inhibitors of DNA Replication in Gram-Positive Bacteria,Confirmatory,,
451,485297,1,1,,90341534,2907,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
452,485298,1,1,,90341534,2907,Inactive,,,,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
453,485313,1,2,,90341534,2907,Inactive,255652944.0,4864.0,,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
454,485314,1,1,,50105634,2907,Inactive,4505931.0,5423.0,,Potency,qHTS Assay for Inhibitors of DNA Polymerase Beta,Confirmatory,,
455,485342,1,2,,90341534,2907,Inactive,5454140.0,7251.0,,Potency,qHTS Validation Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
456,485345,1,2,,90341534,2907,Inactive,,,,Potency,qHTS Validation Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
457,485366,1,2,,90341534,2907,Inactive,4501969.0,154.0,,Potency,qHTS validation assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
458,485368,1,2,,90341534,2907,Inactive,72386991.0,3656265.0,,Potency,qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
459,488745,1,4,,85230959,2907,Inactive,,,,Potency,"Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
460,488752,1,4,,85230959,2907,Inactive,,,,Potency,"Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
461,488772,1,1,,90341534,2907,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
462,488773,1,2,,90341534,2907,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
463,488816,1,1,,90341534,2907,Inactive,4758356.0,2237.0,,Potency,qHTS Validation Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1),Confirmatory,,
464,488837,1,1,,90341534,2907,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
465,488949,1,2,,85230959,2907,Inactive,41055989.0,54737.0,,Potency,qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
466,488949,1,2,,90341534,2907,Inactive,41055989.0,54737.0,,Potency,qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
467,488953,1,1,,90341534,2907,Active,187960037.0,10951.0,0.006,Potency,qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
468,488978,1,1,,90341534,2907,Inactive,45359078.0,,,Potency,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity: MmCpn Primary Screen,Confirmatory,,
469,488979,1,1,,50105634,2907,Inactive,74315350.0,7442.0,,Potency,HTS Assay for Compounds that Act as Enhancers of the Vanilloid Receptor 1,Confirmatory,,
470,488980,1,1,,85230959,2907,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Antagonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
471,488981,1,1,,90341534,2907,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Agonists,Confirmatory,,
472,488982,1,1,,90341534,2907,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Potentiators,Confirmatory,,
473,488983,1,1,,90341534,2907,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Antagonists,Confirmatory,,
474,493106,1,1,,90341534,2907,Inactive,116283940.0,79915.0,,Potency,Validation screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
475,493107,1,1,,90341534,2907,Inactive,116283940.0,79915.0,,Potency,Validation screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
476,493127,1,1,,50105634,2907,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Validation Screen for Agonists,Screening,,
477,493153,1,1,,90341534,2907,Inactive,,4780.0,,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
478,493153,1,1,,90341534,2907,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
479,493164,1,2,,90341534,2907,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
480,493164,1,2,,90341534,2907,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
481,493164,1,2,,90341534,2907,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
482,493189,1,1,,50105634,2907,Inactive,4503895.0,2584.0,,Potency,qHTS Validation Assay for Inhibitors of Human Galactokinase (GALK),Confirmatory,,
483,504327,1,1,,90341534,2907,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
484,504332,1,1,,50105634,2907,Inactive,168985070.0,,0.2818,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
485,504332,1,1,,90341534,2907,Active,168985070.0,,17.7828,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
486,504364,1,1,,85230959,2907,Inactive,7705682.0,51053.0,,Potency,Validation screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells,Confirmatory,,
487,504536,1,1,,90341534,2907,Inactive,5453898.0,5300.0,,Potency,qHTS Validation Assay to Find Inhibitors of Pin1,Confirmatory,,
488,504547,1,1,,90341534,2907,Inactive,115503961.0,4357161.0,,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
489,504548,1,2,,90341534,2907,Inactive,157877932.0,5655980.0,,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Mutase,Confirmatory,,
490,504749,1,3,,104171125,2907,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
491,504749,1,3,2.0,104171125,2907,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
492,504749,1,3,3.0,104171125,2907,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
493,504749,1,3,5.0,104171125,2907,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
494,504749,1,3,9.0,104171125,2907,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
495,504749,1,3,12.0,104171125,2907,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
496,504749,1,3,14.0,104171125,2907,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
497,504749,1,3,20.0,104171125,2907,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
498,504749,1,3,22.0,104171125,2907,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
499,504749,1,3,23.0,104171125,2907,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
500,504749,1,3,27.0,104171125,2907,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
501,504749,1,3,28.0,104171125,2907,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
502,504749,1,3,30.0,104171125,2907,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
503,504749,1,3,31.0,104171125,2907,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
504,504749,1,3,33.0,104171125,2907,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
505,504749,1,3,36.0,104171125,2907,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
506,504749,1,3,38.0,104171125,2907,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
507,504749,1,3,41.0,104171125,2907,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
508,504749,1,3,45.0,104171125,2907,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
509,504749,1,3,50.0,104171125,2907,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
510,504749,1,3,53.0,104171125,2907,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
511,504749,1,3,55.0,104171125,2907,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
512,504749,1,3,59.0,104171125,2907,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
513,504749,1,3,60.0,104171125,2907,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
514,504810,1,2,,90341534,2907,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
515,504812,1,2,,90341534,2907,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
516,504821,1,1,,85230959,2907,Inactive,38016895.0,7253.0,,Potency,Antagonists of the Thyroid Stimulating Hormone Receptor: Validation,Confirmatory,,
517,504832,1,1,,104171125,2907,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
518,504834,1,1,,104171125,2907,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
519,504836,1,2,,90341534,2907,Inactive,168984549.0,,,Potency,Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation,Confirmatory,11836247.0,
520,504845,1,1,,90341534,2907,Inconclusive,86301163.0,5999.0,4.2244,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
521,504847,1,1,,90341534,2907,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
522,504847,1,1,,104171125,2907,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
523,504865,1,1,,90341534,2907,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
524,504865,1,1,,104171125,2907,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
525,526307,4,3,,103171472,2907,Unspecified,,,100.0,IC50,Cytotoxicity against human Hep2 cells by MTT assay,Confirmatory,20850303.0,
526,526308,4,2,,103171472,2907,Active,,,8.79,IC50,Cytotoxicity against human HL60 cells by MTT assay,Confirmatory,20850303.0,
527,526309,4,4,,103171472,2907,Unspecified,,,100.0,IC50,Cytotoxicity against human HEK293T cells by MTT assay,Confirmatory,20850303.0,
528,527625,1,4,,103171472,2907,Unspecified,,,,,"Anticancer activity against mouse S180 cells xenografted in ICR mouse assessed as tumor weight inhibition at 100 mg/kg, ip relative to control",Other,20888764.0,
529,534106,5,2,,103171472,2907,Unspecified,,,,,Antibacterial activity against Pasteurella multocida AL435 after 24 hrs by broth dilution method,Other,18725450.0,
530,534107,5,2,,103171472,2907,Unspecified,,,,,Antibacterial activity against TolC deficient Pasteurella multocida pm0527 after 24 hrs by broth dilution method,Other,18725450.0,
531,534108,5,2,,103171472,2907,Unspecified,,,,,Antibacterial activity against Pasteurella multocida pm0527 after 24 hrs by broth dilution method,Other,18725450.0,
532,534109,1,3,,103171472,2907,Unspecified,,,,,Ratio of MIC for Pasteurella multocida AL435 to MIC for TolC deficient Pasteurella multocida pm0527,Other,18725450.0,
533,534110,5,2,,103171472,2907,Unspecified,,,,,Antibacterial activity against TolC deficient Pasteurella multocida pm1980 after 24 hrs by broth dilution method,Other,18725450.0,
534,534111,5,2,,103171472,2907,Unspecified,,,,,Antibacterial activity against Pasteurella multocida pm1980 after 24 hrs by broth dilution method,Other,18725450.0,
535,534112,1,3,,103171472,2907,Unspecified,,,,,Ratio of MIC for Pasteurella multocida AL435 to MIC for TolC deficient Pasteurella multocida pm1980,Other,18725450.0,
536,537733,2,3,,103171472,2907,Inactive,,,,,Binding affinity to Candida albicans CaCdr1p expressed in yeast AD1-8u,Other,20739103.0,
537,537734,5,2,,103171472,2907,Unspecified,,,,,Antifungal activity against yeast AD1-8u expressing Candida albicans CaMdr1p by agar disk diffusion assay,Other,20739103.0,
538,537735,2,3,,103171472,2907,Inactive,,,,,Binding affinity to Candida albicans CaMdr1p expressed in yeast AD1-8u,Other,20739103.0,
539,537736,5,2,,103171472,2907,Unspecified,,,,,Antifungal activity against yeast AD1-8u expressing Candida albicans CaCdr1p by agar disk diffusion assay,Other,20739103.0,
540,540209,4,3,,103171472,2907,Unspecified,,,,,Volume of distribution at steady state in human after iv administration,Other,18426954.0,
541,540210,4,3,,103171472,2907,Unspecified,,,,,Clearance in human after iv administration,Other,18426954.0,
542,540211,2,5,,103171472,2907,Unspecified,,,,,Fraction unbound in human after iv administration,Other,18426954.0,
543,540212,4,3,,103171472,2907,Unspecified,,,,,Mean residence time in human after iv administration,Other,18426954.0,
544,540213,4,3,,103171472,2907,Unspecified,,,,,Half life in human after iv administration,Other,18426954.0,
545,540214,4,3,,103171472,2907,Unspecified,,,,,Clearance in rat after iv administration,Other,15920768.0,
546,540215,3,2,,103171472,2907,Unspecified,,,,,Volume of distribution at steady state in rat after iv administration,Other,15920768.0,
547,540216,4,3,,103171472,2907,Unspecified,,,,,Clearance in dog after iv administration,Other,15920768.0,
548,540217,4,3,,103171472,2907,Unspecified,,,,,Volume of distribution at steady state in dog after iv administration,Other,15920768.0,
549,540218,4,3,,103171472,2907,Unspecified,,,,,Clearance in monkey after iv administration,Other,15920768.0,
550,540219,4,3,,103171472,2907,Unspecified,,,,,Volume of distribution at steady state in monkey after iv administration,Other,15920768.0,
551,540220,4,3,,103171472,2907,Unspecified,,,,,Clearance in human after iv administration,Other,15920768.0,
552,540221,4,3,,103171472,2907,Unspecified,,,,,Volume of distribution at steady state in human after iv administration,Other,15920768.0,
553,540256,1,2,,50105634,2907,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
554,540256,1,2,,90341534,2907,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
555,540276,1,2,,11110909,2907,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
556,540276,1,2,,50105634,2907,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
557,540276,1,2,,50105635,2907,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
558,540276,1,2,,85230959,2907,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
559,540276,1,2,,90341534,2907,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
560,542214,2,3,,103171472,2907,Unspecified,,,,,"Immunosuppressive activity against MAV-1 infected BALB/c mouse assessed as viral-induced mortality rate at 100 mg/kg, ip treated 8 days before infection for 2 weeks",Other,18268085.0,
561,542215,2,3,,103171472,2907,Unspecified,,,,,"Immunosuppressive activity against MAV-1 infected BALB/c mouse assessed as viral-induced mortality rate at 100 mg/kg, ip treated 8 days before infection for 3 weeks",Other,18268085.0,
562,542216,2,3,,103171472,2907,Unspecified,,,,,"Immunosuppressive activity against MAV-1 infected BALB/c mouse assessed as viral-induced mortality rate at 100 mg/kg, ip treated 8 days before infection for 4 weeks",Other,18268085.0,
563,542217,2,3,,103171472,2907,Unspecified,,,,,"Toxicity in MAV-1 infected nonimmunosuppressed BALB/c mouse assessed as effect on survival at 100 mg/kg, ip treated 8 days before infection for 2 to 4 weeks",Other,18268085.0,
564,542218,2,3,,103171472,2907,Unspecified,,,,,"Toxicity in BALB/c mouse assessed as effect on survival rate at 100 mg/kg, ip after 2 to 4 weeks",Other,18268085.0,
565,542219,2,3,,103171472,2907,Active,,,,,"Immunosuppressive activity against MAV-1 infected BALB/c mouse assessed as leukopenia in lymph node at 100 mg/kg, ip treated 8 days before infection measured 3 days post infection by flow cytometry",Other,18268085.0,
566,542220,2,3,,103171472,2907,Inactive,,,,,"Immunosuppressive activity against MAV-1 infected BALB/c mouse assessed as increase in neutrophils at 100 mg/kg, ip treated 8 days before infection for 2 weeks measured 14 days post infection by flow cytometry",Other,18268085.0,
567,542221,2,3,,103171472,2907,Active,,,,,"Immunosuppressive activity against MAV-1 infected BALB/c mouse assessed as B cells suppression at 100 mg/kg, ip treated 8 days before infection for 4 weeks measured 14 days post infection by flow cytometry",Other,18268085.0,
568,542222,2,3,,103171472,2907,Active,,,,,"Immunosuppressive activity against MAV-1 infected BALB/c mouse assessed as effect on leukocyte proliferation by T-cell stimulus alphaCD3 at 100 mg/kg, ip treated 8 days before infection by flow cytometry",Other,18268085.0,
569,542422,2,4,,103171472,2907,Active,,,,,"Immunosuppressive activity against MAV-1 infected BALB/c mouse assessed as effect on parenchymal inflammation in liver at 100 mg/kg, ip treated 8 days before infection for 2 weeks by flow cytometry",Other,18268085.0,
570,542423,2,5,,103171472,2907,Inactive,,,,,"Antiviral activity against MAV-1 infected in immunocompromized BALB/c mouse assessed as effect on viral DNA load in liver at 100 mg/kg, ip treated 8 days before infection for 3 weeks by RT-PCR",Other,18268085.0,
571,542424,2,5,,103171472,2907,Inactive,,,,,"Antiviral activity against MAV-1 infected in immunocompromized BALB/c mouse assessed as effect on viral DNA load in liver at 100 mg/kg, ip treated 8 days before infection for 4 weeks by RT-PCR",Other,18268085.0,
572,542425,3,5,,103171472,2907,Active,,,,,"Antiviral activity against MAV-1 infected in immunocompromized BALB/c mouse assessed as decrease in viral DNA load in liver at 100 mg/kg, ip treated 8 days before infection measured after 28 days post infection by RT-PCR",Other,18268085.0,
573,542426,2,3,,103171472,2907,Inactive,,,,,"Immunosuppressive activity against MAV-1 infected BALB/c mouse assessed as enhancement of cidofovir-induced antiviral activity at 100 mg/kg, ip cyclophosphamide treated 8 days before infection for 2 to 4 weeks",Other,18268085.0,
574,542427,2,4,,103171472,2907,Inactive,,,,,"Immunosuppressive activity against MAV-1 infected BALB/c mouse assessed as effect on cidofovir-induced effect on viral DNA load in liver at 100 mg/kg, ip treated 8 days before infection for 2 to 3 weeks measured after 62 days postinfection by RT-PCR",Other,18268085.0,
575,542428,3,3,,103171472,2907,Inactive,,,,,"Immunosuppressive activity against MAV-1 infected BALB/c mouse assessed as inhibition of production of protective antibodies at 100 mg/kg, ip treated 8 days before infection for 3 weeks measured after 62 days postinfection",Other,18268085.0,
576,542429,3,3,,103171472,2907,Active,,,,,"Immunosuppressive activity against MAV-1 infected BALB/c mouse assessed as inhibition of production of protective antibodies at 100 mg/kg, ip treated 8 days before infection for 2 weeks measured after 62 days postinfection",Other,18268085.0,
577,542430,2,4,,103171472,2907,Active,,,,,"Immunosuppressive activity against MAV-1 infected BALB/c mouse assessed as effect portal inflammation in liver at 100 mg/kg, ip treated 8 days before infection for 2 weeks by flow cytometry",Other,18268085.0,
578,542431,3,3,,103171472,2907,Active,,,,,"Immunosuppressive activity against MAV-1 infected BALB/c mouse assessed as T cells suppression at 100 mg/kg, ip treated 8 days before infection for 4 weeks measured 14 days post infection by flow cytometry",Other,18268085.0,
579,551483,3,4,,103171472,2907,Active,,,,,"Anticancer activity against human U87MG cells xenografted in athymic mouse assessed as tumor suppression at 80 mg/kg, iv Q2D for 6 days",Other,21106377.0,
580,588209,2,3,,103171472,2907,Unspecified,,,,,Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset,Other,20553011.0,
581,588210,2,4,,103171472,2907,Unspecified,,,,,Human drug-induced liver injury (DILI) modelling dataset from Ekins et al,Other,20843939.0,
582,588211,2,3,,103171472,2907,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",Other,20014752.0,
583,588212,2,3,,103171472,2907,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",Other,20014752.0,
584,588213,2,3,,103171472,2907,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",Other,20014752.0,
585,588214,2,3,,103171472,2907,Active,,,,,"FDA HLAED, liver enzyme composite activity",Other,16472241.0,
586,588215,2,3,,103171472,2907,Active,,,,,"FDA HLAED, alkaline phosphatase increase",Other,16472241.0,
587,588216,2,3,,103171472,2907,Active,,,,,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",Other,16472241.0,
588,588217,2,3,,103171472,2907,Active,,,,,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",Other,16472241.0,
589,588218,2,3,,103171472,2907,Active,,,,,"FDA HLAED, lactate dehydrogenase (LDH) increase",Other,16472241.0,
590,588219,2,3,,103171472,2907,Unspecified,,,,,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",Other,16472241.0,
591,588349,1,1,,90341534,2907,Inactive,,,,Potency,qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay,Confirmatory,,
592,588378,1,1,,90341534,2907,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression: Validation,Confirmatory,,
593,588453,1,1,,85230959,2907,Inconclusive,8659577.0,58819.0,29.9349,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
594,588453,1,1,,90341534,2907,Inactive,8659577.0,58819.0,1.122,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
595,588456,1,1,,90341534,2907,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
596,588579,1,1,,90341534,2907,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
597,588579,1,1,,104171125,2907,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
598,588590,1,1,,50105634,2907,Inactive,154350220.0,11201.0,,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
599,588591,1,1,,50105634,2907,Inactive,5729982.0,5429.0,,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
600,588795,1,1,,90341534,2907,Inactive,4758356.0,2237.0,,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
601,588834,2,1,,50105634,2907,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
602,589033,1,10,,103171472,2907,Unspecified,117205.0,1555.0,,,"Clinically relevant substrates of human liver microsomal P450 enzymes, isoform CYP2B6",Other,,
603,589439,1,4,,103171472,2907,Unspecified,,,,,"Antitumor activity against mouse S180 cells xenografted in Kunming mouse assessed as tumor growth inhibition rate at 20 mg/kg, po administered for 10 days relative to control",Other,21316818.0,
604,589538,1,4,,103171472,2907,Unspecified,,,,,"Antitumor activity against mouse H22 cells xenografted in Kunming mouse assessed as tumor growth inhibition rate at 20 mg/kg, po administered for 10 days relative to control",Other,21316818.0,
605,597811,1,4,,103171472,2907,Unspecified,,,,,"Antitumor activity against mouse H22 tumor-nearing ICR mouse assessed as inhibition of tumor growth at 10 mg/kg, ip for 7 days measured on day 9",Other,21515048.0,
606,602332,1,1,,90341534,2907,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
607,602332,1,1,,104171125,2907,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
608,603744,1,4,,103171472,2907,Unspecified,,,,,"Antitumor activity against mouse H22 cells xenografted in kunming mouse assessed as inhibition of tumor growth at 15 mg/kg, ip for 7 days",Other,21514015.0,
609,604469,1,4,,103171472,2907,Active,,,,,"Antitumor activity against human MX1 cells xenografted in nude mouse adjuvant model assessed as increase in mouse survival time at 120 mg/kg, po BID measured up to 3 weeks",Other,20726512.0,
610,615261,3,2,,103171472,2907,Unspecified,,,71.4,IC50,Cytotoxicity against human HeLa cells by MTT assay,Confirmatory,21689869.0,
611,615262,3,2,,103171472,2907,Unspecified,,,52.5,IC50,Cytotoxicity against human DU145 cells by MTT assay,Confirmatory,21689869.0,
612,624030,1,2,,104171125,2907,Inactive,160794.0,,,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
613,624031,1,2,,104171125,2907,Inactive,,,,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
614,624032,1,2,,104171125,2907,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
615,624044,1,2,,104171125,2907,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
616,624146,1,1,,90341534,2907,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS): LOPAC Validation,Confirmatory,,
617,624147,1,1,,90341534,2907,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors: LOPAC Validation,Confirmatory,,
618,624148,1,2,,90341534,2907,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists: LOPAC Validation,Confirmatory,,
619,624149,1,1,,90341534,2907,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators: LOPAC Validation,Confirmatory,,
620,624170,1,1,,104171125,2907,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
621,624172,1,1,,104171125,2907,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
622,624173,1,3,,90341534,2907,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
623,624173,1,3,,104171125,2907,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
624,624296,1,1,,104171125,2907,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
625,624297,1,1,,104171125,2907,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
626,624349,1,2,,92309008,2907,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
627,624455,1,1,,90341534,2907,Inactive,299681.0,1812.0,,Potency,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF,Confirmatory,,
628,624476,1,1,,90341534,2907,Inactive,,,,Potency,Cytotoxicity counterscreen for NFkB agonists and antagonists,Confirmatory,,
629,624478,1,1,,90341534,2907,Inactive,,,,Potency,qHTS Assay for Identification of Small Molecule Agonists for NFkB Signaling Pathway.,Confirmatory,,
630,624479,1,1,,90341534,2907,Inactive,,,,Potency,qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway.,Confirmatory,,
631,625144,5,5,,103171472,2907,Unspecified,239977155.0,,,IC50,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),Confirmatory,,
632,625145,4,7,,103171472,2907,Unspecified,20138087.0,10800.0,,IC50,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),Confirmatory,,
633,625146,5,5,,103171472,2907,Unspecified,126397.0,100009114.0,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),Confirmatory,,
634,625147,4,7,,103171472,2907,Unspecified,395398606.0,4159.0,,IC50,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),Confirmatory,,
635,625148,4,7,,103171472,2907,Unspecified,60392672.0,4160.0,,IC50,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),Confirmatory,,
636,625149,4,7,,103171472,2907,Unspecified,729996.0,4161.0,,IC50,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),Confirmatory,,
637,625150,5,5,,103171472,2907,Unspecified,113978.0,4128.0,,IC50,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),Confirmatory,,
638,625151,4,7,,103171472,2907,Unspecified,113118.0,1128.0,,IC50,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
639,625152,4,7,,103171472,2907,Unspecified,113122.0,1129.0,,IC50,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
640,625153,4,7,,103171472,2907,Unspecified,113125.0,1131.0,,IC50,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
641,625154,4,7,,103171472,2907,Unspecified,23503039.0,1132.0,,IC50,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
642,625155,4,7,,103171472,2907,Unspecified,543761.0,1133.0,,IC50,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
643,625156,1,9,,103171472,2907,Unspecified,128997.0,4886.0,,,DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY),Other,,
644,625157,6,2,,103171472,2907,Unspecified,1352610.0,4887.0,,IC50,DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY),Confirmatory,,
645,625158,3,4,,103171472,2907,Unspecified,,,,IC50,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),Confirmatory,,
646,625159,5,5,,103171472,2907,Unspecified,266646.0,24598.0,,IC50,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",Confirmatory,,
647,625160,1,9,,103171472,2907,Unspecified,266649.0,18126.0,,,"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)",Other,,
648,625161,4,7,,103171472,2907,Unspecified,311033488.0,4985.0,,IC50,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",Confirmatory,,
649,625162,4,7,,103171472,2907,Unspecified,116242691.0,4986.0,,IC50,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",Confirmatory,,
650,625163,4,7,,103171472,2907,Unspecified,2851402.0,4988.0,,IC50,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",Confirmatory,,
651,625164,1,6,,103171472,2907,Unspecified,,,,,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),Other,,
652,625165,3,4,,103171472,2907,Unspecified,,,,IC50,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),Confirmatory,,
653,625166,3,4,,103171472,2907,Unspecified,,,,IC50,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),Confirmatory,,
654,625167,5,5,,103171472,2907,Unspecified,317373261.0,8654.0,,IC50,DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP),Confirmatory,,
655,625168,4,7,,103171472,2907,Unspecified,129557.0,5724.0,,IC50,DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF),Confirmatory,,
656,625169,1,6,,103171472,2907,Unspecified,,,,,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),Other,,
657,625170,3,4,,103171472,2907,Unspecified,,,,IC50,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),Confirmatory,,
658,625171,4,7,,103171472,2907,Unspecified,7531135.0,3757.0,,IC50,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),Confirmatory,,
659,625172,4,7,,103171472,2907,Unspecified,75071465.0,,,IC50,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),Confirmatory,,
660,625173,5,5,,103171472,2907,Unspecified,2822103.0,100009274.0,,IC50,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",Confirmatory,,
661,625174,5,5,,103171472,2907,Unspecified,266321.0,834.0,,IC50,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",Confirmatory,,
662,625175,5,5,,103171472,2907,Unspecified,115725.0,1511.0,,IC50,"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)",Confirmatory,,
663,625176,1,9,,103171472,2907,Unspecified,119292.0,1991.0,,,"DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)",Other,,
664,625177,5,5,,103171472,2907,Unspecified,116852.0,4312.0,,IC50,"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",Confirmatory,,
665,625178,5,5,,103171472,2907,Unspecified,269849668.0,4318.0,,IC50,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",Confirmatory,,
666,625179,1,9,,103171472,2907,Unspecified,317373571.0,5578.0,,,DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone),Other,,
667,625180,5,5,,103171472,2907,Unspecified,232066.0,5595.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",Confirmatory,,
668,625181,5,5,,103171472,2907,Unspecified,119554.0,5594.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",Confirmatory,,
669,625182,5,5,,103171472,2907,Unspecified,2499600.0,1432.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",Confirmatory,,
670,625183,5,5,,103171472,2907,Unspecified,1352673.0,5530.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)",Confirmatory,,
671,625184,5,5,,103171472,2907,Unspecified,2811086.0,1956.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
672,625185,5,5,,103171472,2907,Unspecified,125370.0,2534.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
673,625186,5,5,,103171472,2907,Unspecified,119533.0,2064.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
674,625187,5,5,,103171472,2907,Unspecified,125474.0,3932.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
675,625188,1,9,,103171472,2907,Unspecified,33112650.0,5788.0,,,"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)",Other,,
676,625189,1,7,,103171472,2907,Unspecified,,,,,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",Other,,
677,625190,4,5,,103171472,2907,Unspecified,,,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),Confirmatory,,
678,625191,4,7,,103171472,2907,Unspecified,112815.0,25075.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),Confirmatory,,
679,625192,4,7,,103171472,2907,Unspecified,543727.0,3356.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),Confirmatory,,
680,625193,5,5,,103171472,2907,Unspecified,113037.0,43.0,,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),Confirmatory,,
681,625194,4,7,,103171472,2907,Unspecified,231473.0,134.0,,IC50,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),Confirmatory,,
682,625195,4,7,,103171472,2907,Unspecified,543740.0,135.0,,IC50,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),Confirmatory,,
683,625196,5,6,,103171472,2907,Unspecified,803374855.0,140.0,,IC50,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),Confirmatory,,
684,625197,3,4,,103171472,2907,Unspecified,,,,IC50,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),Confirmatory,,
685,625198,4,7,,103171472,2907,Unspecified,1168247.0,29412.0,,IC50,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),Confirmatory,,
686,625199,4,7,,103171472,2907,Unspecified,543734.0,24173.0,,IC50,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),Confirmatory,,
687,625200,4,7,,103171472,2907,Unspecified,1168243.0,146.0,,IC50,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),Confirmatory,,
688,625201,4,7,,103171472,2907,Unspecified,1351829.0,150.0,,IC50,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Confirmatory,,
689,625202,4,7,,103171472,2907,Unspecified,613504690.0,151.0,,IC50,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),Confirmatory,,
690,625203,4,7,,103171472,2907,Unspecified,20141211.0,152.0,,IC50,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),Confirmatory,,
691,625204,4,7,,103171472,2907,Unspecified,48429211.0,153.0,,IC50,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),Confirmatory,,
692,625205,4,7,,103171472,2907,Unspecified,296439450.0,154.0,,IC50,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),Confirmatory,,
693,625206,4,7,,103171472,2907,Unspecified,461604.0,155.0,,IC50,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),Confirmatory,,
694,625207,4,7,,103171472,2907,Unspecified,128616.0,6530.0,,IC50,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Confirmatory,,
695,625208,5,5,,103171472,2907,Unspecified,1168407.0,24192.0,,IC50,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),Confirmatory,,
696,625209,4,7,,103171472,2907,Unspecified,1703214.0,186.0,,IC50,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),Confirmatory,,
697,625210,3,4,,103171472,2907,Unspecified,,,,IC50,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",Confirmatory,,
698,625211,1,6,,103171472,2907,Unspecified,,,,,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),Other,,
699,625212,3,4,,103171472,2907,Unspecified,,,,IC50,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),Confirmatory,,
700,625213,4,7,,103171472,2907,Unspecified,2506481.0,624.0,,IC50,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),Confirmatory,,
701,625214,1,9,,103171472,2907,Unspecified,550544247.0,799.0,,,DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)),Other,,
702,625215,3,4,,103171472,2907,Unspecified,,,,IC50,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",Confirmatory,,
703,625216,3,4,,103171472,2907,Unspecified,,,,IC50,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",Confirmatory,,
704,625217,4,7,,103171472,2907,Unspecified,1168220.0,3357.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),Confirmatory,,
705,625218,4,7,,103171472,2907,Unspecified,112816.0,3358.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),Confirmatory,,
706,625219,3,4,,103171472,2907,Unspecified,,,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),Confirmatory,,
707,625220,4,7,,103171472,2907,Unspecified,6224984.0,100135548.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),Confirmatory,,
708,625221,4,7,,103171472,2907,Unspecified,1703010.0,3362.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),Confirmatory,,
709,625222,4,7,,103171472,2907,Unspecified,400630.0,6532.0,,IC50,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",Confirmatory,,
710,625223,4,7,,103171472,2907,Unspecified,74752153.0,10280.0,,IC50,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),Confirmatory,,
711,625224,3,4,,103171472,2907,Unspecified,,,,IC50,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),Confirmatory,,
712,625225,3,4,,103171472,2907,Unspecified,,,,IC50,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",Confirmatory,,
713,625226,4,7,,103171472,2907,Unspecified,128359.0,6869.0,,IC50,DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P),Confirmatory,,
714,625227,4,7,,103171472,2907,Unspecified,229462950.0,6865.0,,IC50,DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968),Confirmatory,,
715,625228,4,7,,103171472,2907,Unspecified,113832.0,24208.0,,IC50,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),Confirmatory,,
716,625229,5,5,,103171472,2907,Unspecified,254763392.0,6916.0,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),Confirmatory,,
717,625230,1,6,,103171472,2907,Unspecified,,,,,"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)",Other,,
718,625231,4,7,,103171472,2907,Unspecified,143811474.0,2321.0,,IC50,DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF),Confirmatory,,
719,625232,1,9,,103171472,2907,Unspecified,418253.0,7433.0,,,DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP),Other,,
720,625233,4,7,,103171472,2907,Unspecified,586197.0,552.0,,IC50,DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr),Confirmatory,,
721,625234,3,4,,103171472,2907,Unspecified,,,,IC50,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",Confirmatory,,
722,625235,4,7,,103171472,2907,Unspecified,115562.0,1268.0,,IC50,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),Confirmatory,,
723,625236,5,5,,103171472,2907,Unspecified,115456.0,760.0,,IC50,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),Confirmatory,,
724,625237,4,7,,103171472,2907,Unspecified,1168965.0,729230.0,,IC50,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),Confirmatory,,
725,625238,4,7,,103171472,2907,Unspecified,1705894.0,1233.0,,IC50,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),Confirmatory,,
726,625239,4,7,,103171472,2907,Unspecified,1705896.0,1234.0,,IC50,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),Confirmatory,,
727,625240,1,9,,103171472,2907,Unspecified,108936015.0,3577.0,,,DRUGMATRIX: Chemokine CXCR1 (IL-8A),Other,,
728,625241,4,7,,103171472,2907,Unspecified,1352454.0,3579.0,,IC50,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),Confirmatory,,
729,625242,4,7,,103171472,2907,Unspecified,416772.0,886.0,,IC50,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",Confirmatory,,
730,625243,5,5,,103171472,2907,Unspecified,317373262.0,5742.0,,IC50,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),Confirmatory,,
731,625244,5,5,,103171472,2907,Unspecified,3915797.0,5743.0,,IC50,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),Confirmatory,,
732,625245,5,5,,103171472,2907,Unspecified,117144.0,1544.0,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
733,625246,1,9,,103171472,2907,Unspecified,308153612.0,1548.0,,,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Other,,
734,625247,5,5,,103171472,2907,Unspecified,60416369.0,1557.0,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
735,625248,5,5,,103171472,2907,Unspecified,6686268.0,1559.0,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
736,625249,5,5,,103171472,2907,Unspecified,84028191.0,1565.0,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
737,625250,5,5,,103171472,2907,Unspecified,117250.0,1571.0,,IC50,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
738,625251,5,5,,103171472,2907,Unspecified,116241312.0,1576.0,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",Confirmatory,,
739,625252,4,7,,103171472,2907,Unspecified,118228.0,1812.0,,IC50,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),Confirmatory,,
740,625253,4,7,,103171472,2907,Unspecified,118206.0,1813.0,,IC50,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),Confirmatory,,
741,625254,4,7,,103171472,2907,Unspecified,1169206.0,1814.0,,IC50,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),Confirmatory,,
742,625255,4,7,,103171472,2907,Unspecified,1345939.0,1815.0,,IC50,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),Confirmatory,,
743,625256,4,7,,103171472,2907,Unspecified,266667.0,6531.0,,IC50,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),Confirmatory,,
744,625257,4,7,,103171472,2907,Unspecified,119606.0,1909.0,,IC50,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),Confirmatory,,
745,625258,4,7,,103171472,2907,Unspecified,544257.0,2099.0,,IC50,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),Confirmatory,,
746,625259,4,7,,103171472,2907,Unspecified,6166154.0,2100.0,,IC50,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),Confirmatory,,
747,625260,3,4,,103171472,2907,Unspecified,,,,IC50,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",Confirmatory,,
748,625261,3,4,,103171472,2907,Unspecified,,,,IC50,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",Confirmatory,,
749,625262,3,4,,103171472,2907,Unspecified,,,,IC50,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",Confirmatory,,
750,625263,4,7,,103171472,2907,Unspecified,121069.0,2908.0,,IC50,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),Confirmatory,,
751,625264,3,4,,103171472,2907,Unspecified,,,,IC50,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",Confirmatory,,
752,625265,1,6,,103171472,2907,Unspecified,,,,,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",Other,,
753,625266,3,4,,103171472,2907,Unspecified,,,,IC50,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",Confirmatory,,
754,625267,3,4,,103171472,2907,Unspecified,,,,IC50,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",Confirmatory,,
755,625268,4,2,,103171472,2907,Unspecified,121579.0,24397.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
756,625268,4,2,,103171472,2907,Unspecified,121580.0,114516.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
757,625268,4,2,,103171472,2907,Unspecified,121604.0,25456.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
758,625268,4,2,,103171472,2907,Unspecified,12230887.0,25674.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
759,625269,4,7,,103171472,2907,Unspecified,547645.0,3269.0,,IC50,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",Confirmatory,,
760,625270,4,7,,103171472,2907,Unspecified,123120.0,3274.0,,IC50,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),Confirmatory,,
761,625271,5,5,,103171472,2907,Unspecified,123343.0,3156.0,,IC50,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),Confirmatory,,
762,625272,3,4,,103171472,2907,Unspecified,,,,IC50,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",Confirmatory,,
763,625273,4,6,,103171472,2907,Unspecified,124531.0,24954.0,,IC50,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),Confirmatory,,
764,625274,1,6,,103171472,2907,Unspecified,,,,,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),Other,,
765,625275,3,4,,103171472,2907,Unspecified,,,,IC50,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",Confirmatory,,
766,625277,1,3,,103171472,2907,Unspecified,,,,,FDA Liver Toxicity Knowledge Base Benchmark Dataset (LTKB-BD) drugs of less concern for DILI,Other,21624500.0,
767,625279,1,3,,103171472,2907,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia,Other,22194678.0,
768,625280,1,3,,103171472,2907,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis,Other,22194678.0,
769,625281,1,3,,103171472,2907,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis,Other,22194678.0,
770,625282,1,3,,103171472,2907,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis,Other,22194678.0,
771,625283,1,3,,103171472,2907,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests,Other,22194678.0,
772,625284,1,3,,103171472,2907,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure,Other,22194678.0,
773,625285,1,3,,103171472,2907,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis,Other,22194678.0,
774,625286,1,3,,103171472,2907,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis,Other,22194678.0,
775,625287,1,3,,103171472,2907,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly,Other,22194678.0,
776,625288,1,3,,103171472,2907,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice,Other,22194678.0,
777,625289,1,3,,103171472,2907,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease,Other,22194678.0,
778,625290,1,3,,103171472,2907,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty,Other,22194678.0,
779,625291,1,3,,103171472,2907,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal,Other,22194678.0,
780,625292,1,3,,103171472,2907,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score,Other,22194678.0,
781,643578,1,4,,103171472,2907,Unspecified,,,,,"Antitumor activity against human H22 cells xenografted in Kunming mouse assessed as reduction in tumor volume at 20 mg/kg, po qd for 10 days",Other,22196118.0,
782,643634,1,4,,103171472,2907,Unspecified,,,,,"Immunostimulatory activity in Kunming mouse xenografted with human H22 cells assessed as change in thymus mass at 20 mg/kg, po qd for 10 days (Rvb = 1.83 +/- 0.85 mg/kg)",Other,22196118.0,
783,643639,1,4,,103171472,2907,Unspecified,,,,,"Toxicity in Kunming mouse xenografted with human H22 cells assessed as change in body weight at 20 mg/kg, po qd for 10 days (Rvb = 25.3 +/- 1.5 g)",Other,22196118.0,
784,643642,1,5,,103171472,2907,Unspecified,,,,,"Immunostimulatory activity in Kunming mouse xenografted with human H22 cells assessed as change in spleen mass at 20 mg/kg, po qd for 10 days (Rvb = 6.61 +/- 1.84 mg/kg)",Other,22196118.0,
785,651635,1,3,,90341534,2907,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
786,651645,1,1,,90341534,2907,Inactive,,,,Potency,Cell Proliferation Assay against the TMD8 Cell Line,Confirmatory,,
787,651646,1,1,,90341534,2907,Inactive,,,,Potency,Cell Proliferation Assay against the HBL1 Cell Line,Confirmatory,,
788,651696,1,1,,90341534,2907,Inactive,,,2.3485,Potency,Cell Proliferation Assay against a hMSC Cell Line,Confirmatory,,
789,651712,1,1,,90341534,2907,Inactive,,,,Potency,Cell Proliferation Assay against the TMD8 Cell Line (Caspase readout at 16 hrs),Confirmatory,,
790,651713,1,1,,90341534,2907,Inactive,,,,Potency,Cell Proliferation Assay against the TMD8 Cell Line (Caspase readout at 8 hrs),Confirmatory,,
791,651828,1,2,,92309008,2907,Inactive,127925.0,,,,A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus,Other,,
792,651828,1,2,,121361121,2907,Inactive,127925.0,,,,A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus,Other,,
793,652106,1,1,,90341534,2907,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
794,678712,1,8,,103171472,2907,Active,117144.0,1544.0,,,Inhibition of human CYP1A2 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using ethoxyresorufin as substrate after 30 mins,Other,22931300.0,
795,678713,1,8,,103171472,2907,Active,6686268.0,1559.0,,,Inhibition of human CYP2C9 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-methoxy-4-trifluoromethylcoumarin-3-acetic acid as substrate after 30 mins,Other,22931300.0,
796,678714,1,8,,103171472,2907,Active,60416369.0,1557.0,,,Inhibition of human CYP2C19 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 3-butyryl-7-methoxycoumarin as substrate after 30 mins,Other,22931300.0,
797,678715,1,8,,103171472,2907,Active,84028191.0,1565.0,,,Inhibition of human CYP2D6 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 4-methylaminoethyl-7-methoxycoumarin as substrate after 30 mins,Other,22931300.0,
798,678716,1,8,,103171472,2907,Active,116241312.0,1576.0,,,Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using diethoxyfluorescein as substrate after 30 mins,Other,22931300.0,
799,678717,1,8,,103171472,2907,Active,116241312.0,1576.0,,,Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-benzyloxyquinoline as substrate after 30 mins,Other,22931300.0,
800,678719,1,5,,103171472,2907,Unspecified,,,,,Metabolic stability in human liver microsomes assessed as medium signal/noise ratio (S/N of 10 to 100) by measuring GSH adduct formation at 100 uM after 90 mins by HPLC-MS analysis,Other,22931300.0,
801,678722,1,5,,103171472,2907,Inconclusive,,,,,Covalent binding affinity to human liver microsomes assessed per mg of protein at 10 uM after 60 mins presence of NADPH,Other,22931300.0,
802,681153,3,6,,103171472,2907,Unspecified,238054374.0,5243.0,,IC50,TP_TRANSPORTER: inhibition of Daunorubicin efflux in NIH-3T3-G185 cells,Confirmatory,11743742.0,
803,686947,2,2,,90341534,2907,Inactive,4885661.0,7525.0,,Potency,qHTS for small molecule inhibitors of Yes1 kinase: Primary Screen,Confirmatory,23787099.0,
804,686950,1,1,,90341534,2907,Inactive,,,,Potency,qHTS for small molecule inhibitors of Yes1 kinase: Counter Assay,Other,,
805,687035,1,1,,163564192,2907,Inactive,125541954.0,,,,Fluorescence polarization based primary biochemical high throughput screening assay of LOPAC1280 to identify inhibitors of hepatitis C non-structural protein 3 helicase,Screening,,
806,687037,1,3,,163564192,2907,Inactive,,,,,Fluorescence-based counterscreen assay of HCV NS3 helicase-DNA binding inhibitors in LOPAC1280: biochemical high-throughput screening assay to identify compounds that enhance or quench fluorescence of a Cy5-DNA-NS3h complex,Screening,,
807,687726,1,2,,103171472,2907,Unspecified,,,,,"Anticancer activity against mouse H22 cells allografted in Kunming mouse at 30 mg/kg, ip for 7 days measured after 7 days",Other,22901410.0,
808,687727,1,2,,103171472,2907,Unspecified,,,,,"Toxicity in Kunming mouse xenografted with mouse H22 cells assessed as increase in body weight at 30 mg/kg, ip for 7 days measured after 7 days",Other,22901410.0,
809,689424,2,2,,103171472,2907,Unspecified,,,,,Antineoplastic activity against mouse LLC cells xenografted in C57BL/6 mouse assessed as tumor growth inhibition at 100 mg/kg/day measured on day 17,Other,22574992.0,
810,689582,2,2,,103171472,2907,Unspecified,,,,,Antineoplastic activity against mouse LLC cells xenografted in C57BL/6 mouse assessed as tumor growth inhibition at 100 mg/kg/day measured on day 11,Other,22574992.0,
811,689583,2,2,,103171472,2907,Unspecified,,,,,Antineoplastic activity against mouse LLC cells xenografted in C57BL/6 mouse assessed as tumor growth inhibition at 100 mg/kg/day measured on day 14,Other,22574992.0,
812,689584,2,2,,103171472,2907,Unspecified,,,,,Antineoplastic activity against mouse LLC cells xenografted in C57BL/6 mouse assessed as tumor growth inhibition at 100 mg/kg/day measured on day 16,Other,22574992.0,
813,689585,2,2,,103171472,2907,Unspecified,,,,,Antineoplastic activity against mouse LLC cells xenografted in C57BL/6 mouse assessed as tumor growth inhibition at 100 mg/kg/day measured on day 18,Other,22574992.0,
814,689586,2,2,,103171472,2907,Unspecified,,,,,Antineoplastic activity against mouse LLC cells xenografted in C57BL/6 mouse assessed as tumor growth inhibition at 100 mg/kg/day measured on day 21,Other,22574992.0,
815,689587,2,2,,103171472,2907,Unspecified,,,,,Antineoplastic activity against mouse LLC cells xenografted in C57BL/6 mouse assessed as tumor growth inhibition at 100 mg/kg/day measured on day 23,Other,22574992.0,
816,689588,2,2,,103171472,2907,Unspecified,,,,,Antineoplastic activity against mouse LLC cells xenografted in C57BL/6 mouse assessed as tumor growth inhibition at 100 mg/kg/day measured on day 12,Other,22574992.0,
817,689589,2,2,,103171472,2907,Unspecified,,,,,Antineoplastic activity against mouse LLC cells xenografted in C57BL/6 mouse assessed as tumor growth inhibition at 100 mg/kg/day measured on day 19,Other,22574992.0,
818,689590,2,2,,103171472,2907,Unspecified,,,,,Antineoplastic activity against mouse LLC cells xenografted in C57BL/6 mouse assessed as tumor growth inhibition at 100 mg/kg/day measured on day 24,Other,22574992.0,
819,693025,1,2,,103171472,2907,Unspecified,,,,,Genotoxicity in human lymphocytes assessed as micronucleated binucleate cells level at 12.5 ug/mL incubated for 3 hrs measured post 21 hrs recovery in presence of rat liver S9 fraction (Rvb = 0.40%),Other,21353728.0,
820,693048,1,2,,103171472,2907,Unspecified,,,,,Genotoxicity in human lymphocytes assessed as micronucleated binucleate cells level at 6.25 ug/mL incubated for 3 hrs measured post 45 hrs recovery in presence of rat liver S9 fraction (Rvb = 0.5%),Other,21353728.0,
821,693061,1,2,,103171472,2907,Unspecified,,,,,Genotoxicity in human lymphocytes assessed as micronucleated binucleate cells level at 12.5 ug/mL incubated for 3 hrs measured post 45 hrs recovery in presence of rat liver S9 fraction (Rvb = 0.0%),Other,21353728.0,
822,693075,1,2,,103171472,2907,Unspecified,,,,,Genotoxicity in human lymphocytes assessed as micronucleated binucleate cells level at 6.25 ug/mL incubated for 3 hrs measured post 45 hrs recovery in presence of rat liver S9 fraction (Rvb = 0.8%),Other,21353728.0,
823,720538,1,2,,90341534,2907,Inactive,220983390.0,410.0,,Potency,qHTS screen for enhancers of Arylsulfatase A (ASA1): LOPAC Validation Assay,Confirmatory,,
824,720559,1,2,,90341534,2907,Inactive,112927.0,351.0,,Potency,qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay,Confirmatory,,
825,720572,1,2,,90341534,2907,Inactive,3063388.0,5071.0,,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (NLuc Reporter),Confirmatory,,
826,720573,1,2,,90341534,2907,Inactive,3063388.0,5071.0,,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (FLuc Reporter),Confirmatory,,
827,720641,1,2,,92309008,2907,Inactive,15923709.0,,,,A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus,Other,,
828,720717,1,3,,92309008,2907,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
829,722893,1,2,,103171472,2907,Unspecified,,,,,Antitumor activity in mouse H22 liver cancer cells inoculated mouse assessed as tumor inhibition rate at one fifth of LD50 concentration once a day for consecutive 7 days by ip,Other,23279863.0,
830,722894,1,2,,103171472,2907,Unspecified,,,,,Antitumor activity in mouse B16 melanoma cell lines cells inoculated mouse assessed as tumor inhibition rate at one fifth of LD50 concentration once a day for consecutive 7 days by ip,Other,23279863.0,
831,722895,1,2,,103171472,2907,Unspecified,,,,,Antitumor activity in mouse Sarcoma 180 cells inoculated mouse assessed as tumor inhibition rate at one fifth of LD50 concentration once a day for consecutive 7 days by ip,Other,23279863.0,
832,722896,1,3,,103171472,2907,Unspecified,,,,,Antitumor activity in mouse Lewis lung cancer cells inoculated mouse assessed as tumor inhibition rate at one fifth of LD50 concentration once a day for consecutive 7 days by ip,Other,23279863.0,
833,722897,1,2,,103171472,2907,Unspecified,,,,,Antitumor activity in mouse CT26 colon cancer cells inoculated mouse assessed as tumor inhibition rate at one fifth of LD50 concentration once a day for consecutive 7 days by ip,Other,23279863.0,
834,722899,1,2,,103171472,2907,Unspecified,,,,,"Toxicity in C57BL/6 mouse assessed as maximum weight loss at 50 mg/kg, ip",Other,23279863.0,
835,724128,1,4,,103171472,2907,Unspecified,,,,,"Antitumor activity against mouse LLC cells xenografted in mouse assessed as tumor inhibition at 30 mg/kg, ip qd for 7 days measured every 3 days for 21 days",Other,23291116.0,
836,724318,1,3,,103171472,2907,Unspecified,,,,,"Antitumor activity against mouse Sarcoma 180 cells xenografted in mouse assessed as tumor inhibition at 30 mg/kg, ip qd for 7 days measured every 3 days for 21 days",Other,23291116.0,
837,724327,1,2,,103171472,2907,Unspecified,,,,,"Neurotoxicity in ip dosed C57BL/6 mouse assessed as tremble, twitch, jumping and supination response",Other,23291116.0,
838,725041,1,3,,103171472,2907,Unspecified,,,125.43,IC50,Cytotoxicity against african green monkey COS1 cells after 24 hrs by MTT assay,Confirmatory,23202484.0,
839,725042,1,3,,103171472,2907,Unspecified,,,64.12,IC50,Cytotoxicity against human PA1 cells after 24 hrs by MTT assay,Confirmatory,23202484.0,
840,725043,1,2,,103171472,2907,Unspecified,,,55.3,IC50,Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay,Confirmatory,23202484.0,
841,725044,1,2,,103171472,2907,Unspecified,,,67.9,IC50,Cytotoxicity against human NCI-H522 cells after 24 hrs by MTT assay,Confirmatory,23202484.0,
842,725045,1,3,,103171472,2907,Unspecified,,,74.32,IC50,Cytotoxicity against human HCT15 cells after 24 hrs by MTT assay,Confirmatory,23202484.0,
843,725046,1,3,,103171472,2907,Unspecified,,,,,Cytotoxicity against human HCT15 cells assessed as growth inhibition at 1 x 10 '-5 M after 24 hrs by MTT assay,Other,23202484.0,
844,725047,1,2,,103171472,2907,Unspecified,,,70.1,IC50,Cytotoxicity against human T47D cells after 24 hrs by MTT assay,Confirmatory,23202484.0,
845,725048,1,2,,103171472,2907,Unspecified,,,,,Cytotoxicity against human HepG2 cells assessed as growth inhibition at 1 x 10 '-5 M after 24 hrs by MTT assay,Other,23202484.0,
846,725049,1,3,,103171472,2907,Unspecified,,,,,Cytotoxicity against human PA1 cells assessed as growth inhibition at 1 x 10 '-5 M after 24 hrs by MTT assay,Other,23202484.0,
847,725050,1,2,,103171472,2907,Unspecified,,,,,Cytotoxicity against human NCI-H522 cells assessed as growth inhibition at 1 x 10 '-5 M after 24 hrs by MTT assay,Other,23202484.0,
848,725051,1,2,,103171472,2907,Unspecified,,,,,Cytotoxicity against human T47D cells assessed as growth inhibition at 1 x 10 '-5 M after 24 hrs by MTT assay,Other,23202484.0,
849,743205,1,1,,90341534,2907,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
850,743205,1,1,,90341534,2907,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
851,743206,1,1,,90341534,2907,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
852,743206,1,1,,90341534,2907,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
853,743207,1,1,,90341534,2907,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
854,743207,1,1,,90341534,2907,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
855,743244,1,1,,90341534,2907,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
856,743322,2,1,,90341534,2907,Inactive,,,0.0084,Potency,qHTS profiling for inhibitors of Plasmodium falciparum (3D7) proliferation,Confirmatory,,
857,743322,2,1,,174007432,2907,Inactive,,,,Potency,qHTS profiling for inhibitors of Plasmodium falciparum (3D7) proliferation,Confirmatory,,
858,743323,2,1,,90341534,2907,Inactive,,,0.0038,Potency,qHTS profiling for inhibitors of Plasmodium falciparum (DD2) proliferation,Confirmatory,,
859,743323,2,1,,174007432,2907,Inactive,,,,Potency,qHTS profiling for inhibitors of Plasmodium falciparum (DD2) proliferation,Confirmatory,,
860,743324,2,1,,90341534,2907,Inactive,,,0.003,Potency,qHTS profiling for inhibitors of Plasmodium falciparum (HB3) proliferation,Confirmatory,,
861,743324,2,1,,174007432,2907,Inactive,,,,Potency,qHTS profiling for inhibitors of Plasmodium falciparum (HB3) proliferation,Confirmatory,,
862,743344,1,1,,174007432,2907,Inactive,,,18.8212,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (3D7) proliferation,Confirmatory,,
863,743345,1,1,,174007432,2907,Inactive,,,16.7744,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation,Confirmatory,,
864,743346,1,1,,174007432,2907,Inactive,,,11.8754,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation (Rep 2),Confirmatory,,
865,743347,1,1,,174007432,2907,Inactive,,,0.0007,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (HB3) proliferation,Confirmatory,,
866,757425,2,2,,103171472,2907,Unspecified,,,,,"Antitumor activity against mouse LLC cells allografted in mouse assessed as tumor growth inhibition at 30 mg/kg, ip qd administered for 7 days measured after 21 days relative to control",Other,23688697.0,
867,757431,2,1,,103171472,2907,Unspecified,,,,,"Antitumor activity against mouse Sarcoma 180 cells allografted in mouse assessed as tumor growth inhibition at 30 mg/kg, ip qd administered for 7 days measured after 21 days relative to control",Other,23688697.0,
868,768693,1,1,,103171472,2907,Unspecified,,,,,"Mutagenicity in Swiss albino mouse at 50 mg/kg, ip after 30 hrs by micronucleus test",Other,23851115.0,
869,871883,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 171/8,Other,,
870,871884,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 171/8,Other,,
871,871885,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 171/8,Other,,
872,871886,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 171/8,Other,,
873,871887,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 171/8,Other,,
874,871888,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 171/8,Other,,
875,871889,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 171/8,Other,,
876,871890,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 171/8,Other,,
877,871891,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 171/8,Other,,
878,871892,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 171/8,Other,,
879,871893,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 171/8,Other,,
880,871894,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 171/8,Other,,
881,871895,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 171/8,Other,,
882,871896,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 171/8,Other,,
883,871929,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 171/15,Other,,
884,871930,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 171/15,Other,,
885,871931,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 171/15,Other,,
886,871932,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 171/15,Other,,
887,871933,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 171/15,Other,,
888,871934,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 171/15,Other,,
889,871935,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 171/15,Other,,
890,871936,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 171/15,Other,,
891,871937,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 171/15,Other,,
892,871938,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 171/16,Other,,
893,871939,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 171/16,Other,,
894,871940,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 171/16,Other,,
895,871941,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 171/16,Other,,
896,871942,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 171/16,Other,,
897,871943,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 171/16,Other,,
898,871944,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 171/16,Other,,
899,871945,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 171/16,Other,,
900,871946,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 171/16,Other,,
901,871947,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 171/16,Other,,
902,871948,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 171/16,Other,,
903,871949,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 171/16,Other,,
904,871950,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 171/16,Other,,
905,871951,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 171/16,Other,,
906,871952,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 171/16,Other,,
907,871953,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 171/16,Other,,
908,871954,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 171/16,Other,,
909,871955,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 171/16,Other,,
910,871956,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 171/16,Other,,
911,871957,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 171/16,Other,,
912,871958,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 171/16,Other,,
913,871959,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 172/5,Other,,
914,871960,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 172/5,Other,,
915,871961,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 172/5,Other,,
916,871962,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 172/5,Other,,
917,871963,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 172/5,Other,,
918,871964,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 172/5,Other,,
919,871965,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 172/5,Other,,
920,871966,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 172/5,Other,,
921,871967,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 172/5,Other,,
922,871968,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 172/5,Other,,
923,871969,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 172/5,Other,,
924,871970,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 172/5,Other,,
925,871971,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 172/5,Other,,
926,871972,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 172/5,Other,,
927,871973,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 172/5,Other,,
928,871974,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 172/5,Other,,
929,872011,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 172/12,Other,,
930,872012,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 172/12,Other,,
931,872013,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 172/12,Other,,
932,872014,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 172/12,Other,,
933,872015,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 172/12,Other,,
934,872016,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 172/12,Other,,
935,872017,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 172/12,Other,,
936,872018,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 172/12,Other,,
937,872019,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 172/12,Other,,
938,872020,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 172/12,Other,,
939,872658,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 172/5,Other,,
940,872703,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 172/13,Other,,
941,872704,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 172/13,Other,,
942,872705,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 172/13,Other,,
943,872706,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 172/13,Other,,
944,872707,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 172/13,Other,,
945,872708,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 172/13,Other,,
946,872709,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 172/13,Other,,
947,872710,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 172/13,Other,,
948,872711,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 172/13,Other,,
949,872712,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 172/13,Other,,
950,872713,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 172/13,Other,,
951,872714,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 172/13,Other,,
952,872715,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 172/13,Other,,
953,872716,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 172/13,Other,,
954,872717,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 172/13,Other,,
955,872718,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 172/13,Other,,
956,872719,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 172/13,Other,,
957,872720,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 172/13,Other,,
958,872721,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 172/13,Other,,
959,872722,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 172/13,Other,,
960,872723,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 172/13,Other,,
961,872724,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 172/14,Other,,
962,872725,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 172/14,Other,,
963,872726,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 172/14,Other,,
964,872727,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 172/14,Other,,
965,872728,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 172/14,Other,,
966,872729,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 172/14,Other,,
967,872730,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 172/14,Other,,
968,872731,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 172/14,Other,,
969,872732,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 172/14,Other,,
970,872733,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 172/14,Other,,
971,872734,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 172/14,Other,,
972,872735,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 172/14,Other,,
973,872736,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 172/14,Other,,
974,872737,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 172/14,Other,,
975,872738,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 172/14,Other,,
976,872739,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 172/14,Other,,
977,872770,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 627/9,Other,,
978,872771,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 627/9,Other,,
979,872772,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 627/9,Other,,
980,872773,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 627/9,Other,,
981,872774,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 627/9,Other,,
982,872775,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 627/9,Other,,
983,872776,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 627/9,Other,,
984,872777,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 627/9,Other,,
985,872778,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 627/9,Other,,
986,872779,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 627/10,Other,,
987,872780,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 627/10,Other,,
988,872781,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 627/10,Other,,
989,872782,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 627/10,Other,,
990,872783,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 627/10,Other,,
991,872784,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 627/10,Other,,
992,872785,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 627/10,Other,,
993,872786,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 627/10,Other,,
994,872787,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 627/10,Other,,
995,872788,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 627/10,Other,,
996,872789,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 627/10,Other,,
997,872790,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 627/10,Other,,
998,872791,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 627/10,Other,,
999,872792,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 627/10,Other,,
1000,873475,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 627/10,Other,,
1001,873476,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 627/10,Other,,
1002,873477,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 627/10,Other,,
1003,873478,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 627/10,Other,,
1004,873479,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 627/10,Other,,
1005,873480,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 627/10,Other,,
1006,873481,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 627/10,Other,,
1007,873482,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 627/11,Other,,
1008,873483,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 627/11,Other,,
1009,873484,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 627/11,Other,,
1010,873485,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 627/11,Other,,
1011,873486,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 627/11,Other,,
1012,873487,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 627/11,Other,,
1013,873488,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 627/11,Other,,
1014,873489,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 627/11,Other,,
1015,873490,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 627/11,Other,,
1016,873491,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 627/11,Other,,
1017,873492,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 627/11,Other,,
1018,873493,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 627/11,Other,,
1019,873494,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 627/11,Other,,
1020,873495,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 627/11,Other,,
1021,873496,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 627/11,Other,,
1022,873497,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 627/11,Other,,
1023,873498,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 627/11,Other,,
1024,873499,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 627/11,Other,,
1025,874089,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 171/8,Other,,
1026,874090,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 171/8,Other,,
1027,874091,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 171/8,Other,,
1028,874092,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 171/8,Other,,
1029,874093,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 171/8,Other,,
1030,874094,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 171/8,Other,,
1031,874095,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 171/8,Other,,
1032,874096,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 171/9,Other,,
1033,874097,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 171/9,Other,,
1034,874098,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 171/9,Other,,
1035,874099,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 171/9,Other,,
1036,874100,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 171/9,Other,,
1037,874101,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 171/9,Other,,
1038,874102,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 171/9,Other,,
1039,874103,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 171/9,Other,,
1040,874104,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 171/9,Other,,
1041,874105,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 171/9,Other,,
1042,874106,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 171/9,Other,,
1043,874107,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 171/9,Other,,
1044,874108,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 171/9,Other,,
1045,874109,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 171/9,Other,,
1046,874110,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 171/9,Other,,
1047,874111,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 171/9,Other,,
1048,874112,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 171/9,Other,,
1049,874113,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 171/9,Other,,
1050,874114,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 171/9,Other,,
1051,874794,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 171/9,Other,,
1052,874795,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 171/9,Other,,
1053,874796,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 171/10,Other,,
1054,874797,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 171/10,Other,,
1055,874798,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 171/10,Other,,
1056,874799,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 171/10,Other,,
1057,874800,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 171/10,Other,,
1058,874801,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 171/10,Other,,
1059,874802,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 171/10,Other,,
1060,874803,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 171/10,Other,,
1061,874804,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 171/10,Other,,
1062,874805,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 171/10,Other,,
1063,874806,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 171/10,Other,,
1064,874807,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 171/10,Other,,
1065,874808,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 171/10,Other,,
1066,874809,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 171/10,Other,,
1067,874810,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 171/10,Other,,
1068,874811,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 171/10,Other,,
1069,874812,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 171/10,Other,,
1070,874813,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 171/10,Other,,
1071,874814,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 171/10,Other,,
1072,874815,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 171/10,Other,,
1073,874849,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 172/5,Other,,
1074,874850,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 172/5,Other,,
1075,874851,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 172/5,Other,,
1076,874852,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 172/5,Other,,
1077,874853,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 172/6,Other,,
1078,874854,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 172/6,Other,,
1079,874855,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 172/6,Other,,
1080,874856,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 172/6,Other,,
1081,874857,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 172/6,Other,,
1082,874858,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 172/6,Other,,
1083,874859,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 172/6,Other,,
1084,874860,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 172/6,Other,,
1085,874861,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 172/6,Other,,
1086,874862,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 172/6,Other,,
1087,874863,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 172/6,Other,,
1088,874864,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 172/6,Other,,
1089,874865,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 172/6,Other,,
1090,874866,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 172/6,Other,,
1091,874867,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 172/6,Other,,
1092,874868,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 172/6,Other,,
1093,874869,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 172/6,Other,,
1094,874870,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 172/6,Other,,
1095,874871,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 172/6,Other,,
1096,874872,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 172/6,Other,,
1097,874873,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 172/6,Other,,
1098,874874,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 172/7,Other,,
1099,874875,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 172/7,Other,,
1100,874876,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 172/7,Other,,
1101,874877,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 172/7,Other,,
1102,874878,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 172/7,Other,,
1103,874879,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 172/7,Other,,
1104,874880,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 172/7,Other,,
1105,874881,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 172/7,Other,,
1106,874882,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 172/7,Other,,
1107,874883,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 172/7,Other,,
1108,874884,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 172/7,Other,,
1109,874929,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 172/14,Other,,
1110,874930,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 172/14,Other,,
1111,875569,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 172/7,Other,,
1112,875570,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 172/7,Other,,
1113,875571,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 172/7,Other,,
1114,875572,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 172/7,Other,,
1115,875573,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 172/7,Other,,
1116,875574,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 172/7,Other,,
1117,875575,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 172/7,Other,,
1118,875576,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 172/7,Other,,
1119,875577,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 172/7,Other,,
1120,875578,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 172/7,Other,,
1121,875579,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 172/8,Other,,
1122,875614,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 172/14,Other,,
1123,875615,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 172/14,Other,,
1124,875616,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 172/14,Other,,
1125,875617,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 172/15,Other,,
1126,875618,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 172/15,Other,,
1127,875619,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 172/15,Other,,
1128,875620,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 172/15,Other,,
1129,875621,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 172/15,Other,,
1130,875622,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 172/15,Other,,
1131,875623,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 172/15,Other,,
1132,875624,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 172/15,Other,,
1133,875625,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 172/15,Other,,
1134,875626,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 172/15,Other,,
1135,875627,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 172/15,Other,,
1136,875628,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 172/15,Other,,
1137,875629,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 172/15,Other,,
1138,875630,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 172/15,Other,,
1139,875631,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 172/15,Other,,
1140,875632,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 172/15,Other,,
1141,875633,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 172/15,Other,,
1142,875634,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 172/15,Other,,
1143,875635,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 172/15,Other,,
1144,875636,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 172/15,Other,,
1145,875637,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 172/15,Other,,
1146,875638,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 172/16,Other,,
1147,875639,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 172/16,Other,,
1148,875640,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 172/16,Other,,
1149,875641,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 172/16,Other,,
1150,875642,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 172/16,Other,,
1151,875643,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 172/16,Other,,
1152,875644,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 172/16,Other,,
1153,875645,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 172/16,Other,,
1154,875646,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 172/16,Other,,
1155,875647,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 172/16,Other,,
1156,875648,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 172/16,Other,,
1157,875649,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 172/16,Other,,
1158,875650,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 172/16,Other,,
1159,875651,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 172/16,Other,,
1160,875652,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 172/16,Other,,
1161,875653,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 172/16,Other,,
1162,875654,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 172/16,Other,,
1163,875655,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 172/16,Other,,
1164,875656,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 172/16,Other,,
1165,875657,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 172/16,Other,,
1166,875658,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 172/16,Other,,
1167,875690,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 627/11,Other,,
1168,875691,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 627/11,Other,,
1169,875692,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 627/11,Other,,
1170,875693,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 627/12,Other,,
1171,875694,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 627/12,Other,,
1172,875695,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 627/12,Other,,
1173,875696,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 627/12,Other,,
1174,875697,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 627/12,Other,,
1175,875698,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 627/12,Other,,
1176,875699,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 627/12,Other,,
1177,875700,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 627/12,Other,,
1178,875701,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 627/12,Other,,
1179,875702,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 627/12,Other,,
1180,875703,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 627/12,Other,,
1181,876386,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 627/12,Other,,
1182,876387,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 627/12,Other,,
1183,876388,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 627/12,Other,,
1184,876389,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 627/12,Other,,
1185,876390,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 627/12,Other,,
1186,876391,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 627/12,Other,,
1187,876392,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 627/12,Other,,
1188,876393,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 627/12,Other,,
1189,876394,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 627/12,Other,,
1190,876395,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 627/12,Other,,
1191,876396,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 627/13,Other,,
1192,876397,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 627/13,Other,,
1193,876398,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 627/13,Other,,
1194,876399,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 627/13,Other,,
1195,876400,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 627/13,Other,,
1196,876401,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 627/13,Other,,
1197,876402,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 627/13,Other,,
1198,876403,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 627/13,Other,,
1199,876404,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 627/13,Other,,
1200,876405,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 627/13,Other,,
1201,876406,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 627/13,Other,,
1202,876407,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 627/13,Other,,
1203,876408,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 627/13,Other,,
1204,876409,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 627/13,Other,,
1205,876410,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 627/13,Other,,
1206,876411,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 627/13,Other,,
1207,876412,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 627/13,Other,,
1208,876413,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 627/13,Other,,
1209,876414,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 627/13,Other,,
1210,876415,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 627/13,Other,,
1211,876416,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 627/13,Other,,
1212,876417,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 627/14,Other,,
1213,876418,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 627/14,Other,,
1214,876419,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 627/14,Other,,
1215,877007,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 171/10,Other,,
1216,877008,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 171/11,Other,,
1217,877009,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 171/11,Other,,
1218,877010,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 171/11,Other,,
1219,877011,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 171/11,Other,,
1220,877012,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 171/11,Other,,
1221,877013,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 171/11,Other,,
1222,877014,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 171/11,Other,,
1223,877015,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 171/11,Other,,
1224,877016,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 171/11,Other,,
1225,877017,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 171/11,Other,,
1226,877018,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 171/11,Other,,
1227,877019,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 171/11,Other,,
1228,877020,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 171/11,Other,,
1229,877021,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 171/11,Other,,
1230,877022,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 171/11,Other,,
1231,877023,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 171/11,Other,,
1232,877024,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 171/11,Other,,
1233,877705,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 171/11,Other,,
1234,877706,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 171/11,Other,,
1235,877707,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 171/11,Other,,
1236,877708,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 171/11,Other,,
1237,877709,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 171/12,Other,,
1238,877710,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 171/12,Other,,
1239,877711,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 171/12,Other,,
1240,877712,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 171/12,Other,,
1241,877713,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 171/12,Other,,
1242,877714,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 171/12,Other,,
1243,877715,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 171/12,Other,,
1244,877716,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 171/12,Other,,
1245,877717,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 171/12,Other,,
1246,877718,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 171/12,Other,,
1247,877719,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 171/12,Other,,
1248,877720,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 171/12,Other,,
1249,877721,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 171/12,Other,,
1250,877722,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 171/12,Other,,
1251,877723,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 171/12,Other,,
1252,877724,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 171/12,Other,,
1253,877725,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 171/12,Other,,
1254,877726,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 171/12,Other,,
1255,877727,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 171/12,Other,,
1256,877728,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 171/12,Other,,
1257,877729,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 171/12,Other,,
1258,877730,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 171/13,Other,,
1259,877731,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 171/13,Other,,
1260,877732,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 171/13,Other,,
1261,877733,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 171/13,Other,,
1262,877734,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 171/13,Other,,
1263,877767,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 172/8,Other,,
1264,877768,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 172/8,Other,,
1265,877769,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 172/8,Other,,
1266,877770,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 172/8,Other,,
1267,877771,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 172/8,Other,,
1268,877772,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 172/8,Other,,
1269,877773,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 172/8,Other,,
1270,877774,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 172/8,Other,,
1271,877775,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 172/8,Other,,
1272,877776,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 172/8,Other,,
1273,877777,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 172/8,Other,,
1274,877778,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 172/8,Other,,
1275,877779,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 172/8,Other,,
1276,877780,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 172/8,Other,,
1277,877781,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 172/8,Other,,
1278,877782,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 172/8,Other,,
1279,877783,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 172/8,Other,,
1280,877784,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 172/8,Other,,
1281,877785,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 172/8,Other,,
1282,877786,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 172/8,Other,,
1283,877787,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 172/9,Other,,
1284,877788,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 172/9,Other,,
1285,877789,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 172/9,Other,,
1286,877790,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 172/9,Other,,
1287,877791,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 172/9,Other,,
1288,877792,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 172/9,Other,,
1289,877793,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 172/9,Other,,
1290,877794,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 172/9,Other,,
1291,878478,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 172/9,Other,,
1292,878479,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 172/9,Other,,
1293,878480,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 172/9,Other,,
1294,878481,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 172/9,Other,,
1295,878482,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 172/9,Other,,
1296,878483,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 172/9,Other,,
1297,878484,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 172/9,Other,,
1298,878485,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 172/9,Other,,
1299,878486,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 172/9,Other,,
1300,878487,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 172/9,Other,,
1301,878488,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 172/9,Other,,
1302,878489,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 172/9,Other,,
1303,878490,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 172/9,Other,,
1304,878491,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 172/10,Other,,
1305,878492,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 172/10,Other,,
1306,878493,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 172/10,Other,,
1307,878494,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 172/10,Other,,
1308,878495,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 172/10,Other,,
1309,878496,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 172/10,Other,,
1310,878529,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 627/5,Other,,
1311,878530,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 627/5,Other,,
1312,878531,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 627/5,Other,,
1313,878532,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 627/5,Other,,
1314,878533,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 627/5,Other,,
1315,878534,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 627/5,Other,,
1316,878535,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 627/5,Other,,
1317,878536,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 627/5,Other,,
1318,878537,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 627/5,Other,,
1319,878538,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 627/5,Other,,
1320,878539,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 627/5,Other,,
1321,878540,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 627/5,Other,,
1322,878541,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 627/5,Other,,
1323,878542,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 627/5,Other,,
1324,878543,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 627/5,Other,,
1325,878544,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 627/5,Other,,
1326,878545,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 627/5,Other,,
1327,878546,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 627/5,Other,,
1328,878547,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 627/5,Other,,
1329,878548,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 627/5,Other,,
1330,878549,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 627/5,Other,,
1331,878550,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 627/6,Other,,
1332,878551,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 627/6,Other,,
1333,878552,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 627/6,Other,,
1334,878553,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 627/6,Other,,
1335,878554,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 627/6,Other,,
1336,878555,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 627/6,Other,,
1337,878556,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 627/6,Other,,
1338,878557,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 627/6,Other,,
1339,878558,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 627/6,Other,,
1340,878559,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 627/6,Other,,
1341,878560,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 627/6,Other,,
1342,878561,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 627/6,Other,,
1343,878562,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 627/6,Other,,
1344,878563,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 627/6,Other,,
1345,878564,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 627/6,Other,,
1346,878565,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 627/6,Other,,
1347,878566,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 627/6,Other,,
1348,878567,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 627/6,Other,,
1349,878568,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 627/6,Other,,
1350,878609,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 627/14,Other,,
1351,878610,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 627/14,Other,,
1352,878611,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 627/14,Other,,
1353,878612,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 627/14,Other,,
1354,878613,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 627/14,Other,,
1355,879252,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 627/6,Other,,
1356,879253,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 627/6,Other,,
1357,879254,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 627/7,Other,,
1358,879255,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 627/7,Other,,
1359,879256,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 627/7,Other,,
1360,879257,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 627/7,Other,,
1361,879258,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 627/7,Other,,
1362,879259,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 627/7,Other,,
1363,879297,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 627/14,Other,,
1364,879298,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 627/14,Other,,
1365,879299,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 627/14,Other,,
1366,879300,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 627/14,Other,,
1367,879301,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 627/14,Other,,
1368,879302,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 627/14,Other,,
1369,879303,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 627/14,Other,,
1370,879304,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 627/14,Other,,
1371,879305,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 627/14,Other,,
1372,879306,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 627/14,Other,,
1373,879307,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 627/14,Other,,
1374,879308,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 627/14,Other,,
1375,879309,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 627/14,Other,,
1376,879310,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 627/15,Other,,
1377,879311,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 627/15,Other,,
1378,879312,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 627/15,Other,,
1379,879313,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 627/15,Other,,
1380,879314,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 627/15,Other,,
1381,879315,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 627/15,Other,,
1382,879316,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 627/15,Other,,
1383,879317,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 627/15,Other,,
1384,879318,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 627/15,Other,,
1385,879319,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 627/15,Other,,
1386,879320,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 627/15,Other,,
1387,879321,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 627/15,Other,,
1388,879322,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 627/15,Other,,
1389,879323,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 627/15,Other,,
1390,879324,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 627/15,Other,,
1391,879325,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 627/15,Other,,
1392,879326,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 627/15,Other,,
1393,879327,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 627/15,Other,,
1394,879328,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 627/15,Other,,
1395,879329,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 627/15,Other,,
1396,879330,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 627/15,Other,,
1397,879331,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 627/16,Other,,
1398,879332,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 627/16,Other,,
1399,879333,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 627/16,Other,,
1400,879334,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 627/16,Other,,
1401,879335,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 627/16,Other,,
1402,879336,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 627/16,Other,,
1403,879337,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 627/16,Other,,
1404,879338,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 627/16,Other,,
1405,879339,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 627/16,Other,,
1406,879926,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 171/13,Other,,
1407,879927,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 171/13,Other,,
1408,879928,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 171/13,Other,,
1409,879929,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 171/13,Other,,
1410,879930,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 171/13,Other,,
1411,879931,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 171/13,Other,,
1412,879932,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 171/13,Other,,
1413,879933,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 171/13,Other,,
1414,879934,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 171/13,Other,,
1415,880575,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 627/16,Other,,
1416,880576,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 627/16,Other,,
1417,880577,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 627/16,Other,,
1418,880578,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 627/16,Other,,
1419,880579,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 627/16,Other,,
1420,880580,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 627/16,Other,,
1421,880581,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 627/16,Other,,
1422,880582,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 627/16,Other,,
1423,880583,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 627/16,Other,,
1424,880584,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 627/16,Other,,
1425,880585,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 627/16,Other,,
1426,880586,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 627/16,Other,,
1427,880615,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 171/13,Other,,
1428,880616,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 171/13,Other,,
1429,880617,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 171/13,Other,,
1430,880618,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 171/13,Other,,
1431,880619,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 171/13,Other,,
1432,880620,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 171/13,Other,,
1433,880621,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 171/13,Other,,
1434,880622,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 171/14,Other,,
1435,880623,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 171/14,Other,,
1436,880624,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 171/14,Other,,
1437,880625,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 171/14,Other,,
1438,880626,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 171/14,Other,,
1439,880627,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 171/14,Other,,
1440,880628,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 171/14,Other,,
1441,880629,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 171/14,Other,,
1442,880630,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 171/14,Other,,
1443,880631,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 171/14,Other,,
1444,880632,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 171/14,Other,,
1445,880633,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 171/14,Other,,
1446,880634,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 171/14,Other,,
1447,880635,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 171/14,Other,,
1448,880636,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 171/14,Other,,
1449,880637,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 171/14,Other,,
1450,880638,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 171/14,Other,,
1451,880639,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 171/14,Other,,
1452,880640,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 171/14,Other,,
1453,880641,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 171/14,Other,,
1454,880642,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 171/14,Other,,
1455,880643,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 171/15,Other,,
1456,880644,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 171/15,Other,,
1457,880645,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 171/15,Other,,
1458,880646,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 171/15,Other,,
1459,880647,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 171/15,Other,,
1460,880648,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 171/15,Other,,
1461,880649,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 171/15,Other,,
1462,880650,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 171/15,Other,,
1463,880651,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 171/15,Other,,
1464,880652,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 171/15,Other,,
1465,880653,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 171/15,Other,,
1466,880687,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 172/10,Other,,
1467,880688,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 172/10,Other,,
1468,880689,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 172/10,Other,,
1469,880690,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 172/10,Other,,
1470,880691,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 172/10,Other,,
1471,880692,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 172/10,Other,,
1472,880693,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 172/10,Other,,
1473,880694,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 172/10,Other,,
1474,880695,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 172/10,Other,,
1475,880696,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 172/10,Other,,
1476,880697,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 172/10,Other,,
1477,880698,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 172/10,Other,,
1478,880699,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 172/10,Other,,
1479,880700,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 172/10,Other,,
1480,880701,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 172/10,Other,,
1481,880702,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 172/11,Other,,
1482,880703,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 172/11,Other,,
1483,880704,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 172/11,Other,,
1484,880705,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 172/11,Other,,
1485,881388,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 172/11,Other,,
1486,881389,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 172/11,Other,,
1487,881390,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 172/11,Other,,
1488,881391,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 172/11,Other,,
1489,881392,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 172/11,Other,,
1490,881393,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 172/11,Other,,
1491,881394,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 172/11,Other,,
1492,881395,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 172/11,Other,,
1493,881396,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 172/11,Other,,
1494,881397,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 172/11,Other,,
1495,881398,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 172/11,Other,,
1496,881399,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 172/11,Other,,
1497,881400,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 172/11,Other,,
1498,881401,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 172/11,Other,,
1499,881402,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 172/11,Other,,
1500,881403,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 172/11,Other,,
1501,881404,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 172/11,Other,,
1502,881405,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 172/12,Other,,
1503,881406,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 172/12,Other,,
1504,881407,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 172/12,Other,,
1505,881408,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 172/12,Other,,
1506,881409,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 172/12,Other,,
1507,881410,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 172/12,Other,,
1508,881411,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 172/12,Other,,
1509,881412,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 172/12,Other,,
1510,881413,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 172/12,Other,,
1511,881414,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 172/12,Other,,
1512,881415,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 172/12,Other,,
1513,881447,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 627/7,Other,,
1514,881448,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 627/7,Other,,
1515,881449,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 627/7,Other,,
1516,881450,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 627/7,Other,,
1517,881451,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 627/7,Other,,
1518,881452,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 627/7,Other,,
1519,881453,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 627/7,Other,,
1520,881454,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 627/7,Other,,
1521,881455,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 627/7,Other,,
1522,881456,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 627/7,Other,,
1523,881457,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 627/7,Other,,
1524,881458,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 627/7,Other,,
1525,881459,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 627/7,Other,,
1526,881460,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 627/7,Other,,
1527,881461,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 627/7,Other,,
1528,881462,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 627/8,Other,,
1529,881463,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 627/8,Other,,
1530,881464,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 627/8,Other,,
1531,881465,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 627/8,Other,,
1532,881466,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 627/8,Other,,
1533,881467,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 627/8,Other,,
1534,881468,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 627/8,Other,,
1535,881469,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 627/8,Other,,
1536,881470,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 627/8,Other,,
1537,881471,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 627/8,Other,,
1538,881472,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 627/8,Other,,
1539,881473,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 627/8,Other,,
1540,881474,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 627/8,Other,,
1541,881475,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 627/8,Other,,
1542,881476,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 627/8,Other,,
1543,881477,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 627/8,Other,,
1544,881478,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 627/8,Other,,
1545,881499,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 171/5,Other,,
1546,881500,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 171/5,Other,,
1547,881501,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 171/5,Other,,
1548,881502,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 171/5,Other,,
1549,881503,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 171/5,Other,,
1550,881504,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 171/5,Other,,
1551,881505,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 171/5,Other,,
1552,881506,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 171/5,Other,,
1553,881507,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 171/5,Other,,
1554,881508,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 171/5,Other,,
1555,881509,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 171/5,Other,,
1556,881510,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 171/5,Other,,
1557,881511,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 171/5,Other,,
1558,881512,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 171/5,Other,,
1559,881513,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 171/5,Other,,
1560,881514,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 171/5,Other,,
1561,881515,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 171/5,Other,,
1562,881516,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 171/5,Other,,
1563,881517,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 171/5,Other,,
1564,881518,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 171/5,Other,,
1565,881519,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 171/5,Other,,
1566,881520,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 171/6,Other,,
1567,881521,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 171/6,Other,,
1568,881522,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 171/6,Other,,
1569,881523,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 171/6,Other,,
1570,881524,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 171/6,Other,,
1571,882163,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 627/8,Other,,
1572,882164,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 627/8,Other,,
1573,882165,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 627/8,Other,,
1574,882166,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 627/8,Other,,
1575,882167,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 627/9,Other,,
1576,882168,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 627/9,Other,,
1577,882169,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 627/9,Other,,
1578,882170,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 627/9,Other,,
1579,882171,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 627/9,Other,,
1580,882172,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 627/9,Other,,
1581,882173,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 627/9,Other,,
1582,882174,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 627/9,Other,,
1583,882175,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 627/9,Other,,
1584,882176,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 627/9,Other,,
1585,882177,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 627/9,Other,,
1586,882178,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 627/9,Other,,
1587,882208,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 171/6,Other,,
1588,882209,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 171/6,Other,,
1589,882210,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 171/6,Other,,
1590,882766,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 171/6,Other,,
1591,882767,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 171/6,Other,,
1592,882768,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 171/6,Other,,
1593,882769,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 171/6,Other,,
1594,882770,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 171/6,Other,,
1595,882771,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 171/6,Other,,
1596,882772,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 171/6,Other,,
1597,882773,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 171/6,Other,,
1598,882774,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 171/6,Other,,
1599,882775,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 171/6,Other,,
1600,882776,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 171/6,Other,,
1601,882777,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 171/6,Other,,
1602,882778,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 171/6,Other,,
1603,882779,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 171/7,Other,,
1604,882780,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 171/7,Other,,
1605,882781,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 171/7,Other,,
1606,882782,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 171/7,Other,,
1607,882783,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 171/7,Other,,
1608,882784,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 171/7,Other,,
1609,882785,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 171/7,Other,,
1610,882786,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 171/7,Other,,
1611,882787,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 171/7,Other,,
1612,882788,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 171/7,Other,,
1613,882789,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 171/7,Other,,
1614,882790,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 171/7,Other,,
1615,882791,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 171/7,Other,,
1616,882792,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 171/7,Other,,
1617,882793,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 171/7,Other,,
1618,882794,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 171/7,Other,,
1619,882795,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 171/7,Other,,
1620,882796,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 171/7,Other,,
1621,882797,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 171/7,Other,,
1622,882798,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 171/7,Other,,
1623,882799,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 171/7,Other,,
1624,882846,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 171/15,Other,,
1625,931760,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: BASO (Basophils); Study_ID: S020115,Other,,
1626,931761,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: S020115,Other,,
1627,931762,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: S020115,Other,,
1628,931763,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: EOS (Eosinophils); Study_ID: S020115,Other,,
1629,931764,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: S020115,Other,,
1630,932394,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: RBCNUC (Nucleated Erythrocytes); Study_ID: S020115,Other,,
1631,932395,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: S020115,Other,,
1632,932396,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: S020115,Other,,
1633,932397,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: S020115,Other,,
1634,932398,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: LYM (Lymphocytes); Study_ID: S020115,Other,,
1635,932399,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: S020115,Other,,
1636,932400,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: S020115,Other,,
1637,932401,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: S020115,Other,,
1638,932402,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: MONO (Monocytes); Study_ID: S020115,Other,,
1639,932403,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: S020115,Other,,
1640,932404,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: S020115,Other,,
1641,932405,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: NEUTSG (Neutrophils, Segmented); Study_ID: S020115",Other,,
1642,932406,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: S020115,Other,,
1643,932407,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: S020115,Other,,
1644,937265,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: BASO (Basophils); Study_ID: S020115,Other,,
1645,937266,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: S020115,Other,,
1646,937267,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: S020115,Other,,
1647,937268,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: S020115,Other,,
1648,937269,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: S020115,Other,,
1649,937270,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: S020115,Other,,
1650,937271,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: S020115,Other,,
1651,937272,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: EOS (Eosinophils); Study_ID: S020115,Other,,
1652,937273,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: S020115,Other,,
1653,937274,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: RBCNUC (Nucleated Erythrocytes); Study_ID: S020115,Other,,
1654,937275,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: NEUTSG (Neutrophils, Segmented); Study_ID: S020115",Other,,
1655,937276,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: S020115,Other,,
1656,937277,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: S020115,Other,,
1657,937278,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: LYM (Lymphocytes); Study_ID: S020115,Other,,
1658,937279,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: MONO (Monocytes); Study_ID: S020115,Other,,
1659,937280,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: S020115,Other,,
1660,937281,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: S020115,Other,,
1661,937282,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: S020115,Other,,
1662,937283,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: S020115,Other,,
1663,955657,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: S020115,Other,,
1664,956226,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: CK (Creatine Kinase); Study_ID: S020115,Other,,
1665,956227,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: S020115,Other,,
1666,956228,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: S020115,Other,,
1667,956229,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: S020115,Other,,
1668,956230,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: S020115,Other,,
1669,956231,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: S020115,Other,,
1670,956232,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: S020115,Other,,
1671,956233,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: S020115,Other,,
1672,956234,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: S020115,Other,,
1673,956235,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: S020115,Other,,
1674,956236,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: S020115,Other,,
1675,956237,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: S020115,Other,,
1676,956238,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: S020115,Other,,
1677,956239,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: S020115,Other,,
1678,956240,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: S020115,Other,,
1679,956241,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: S020115,Other,,
1680,956242,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: S020115,Other,,
1681,956243,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: S020115,Other,,
1682,960113,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: S020115,Other,,
1683,960114,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: S020115,Other,,
1684,960115,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: S020115,Other,,
1685,965903,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: S020115,Other,,
1686,965904,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: S020115,Other,,
1687,965905,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: S020115,Other,,
1688,965906,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: S020115,Other,,
1689,965907,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: S020115,Other,,
1690,965908,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: CK (Creatine Kinase); Study_ID: S020115,Other,,
1691,965909,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: S020115,Other,,
1692,965910,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: S020115,Other,,
1693,965911,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: S020115,Other,,
1694,965912,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: S020115,Other,,
1695,965913,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: S020115,Other,,
1696,965914,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: S020115,Other,,
1697,965915,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: S020115,Other,,
1698,965916,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: S020115,Other,,
1699,965917,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: S020115,Other,,
1700,965918,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: S020115,Other,,
1701,995446,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Increased Mitoses; Study_ID: S020115",Other,,
1702,995447,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Lipid Accumulation, Microvesicular; Study_ID: S020115",Other,,
1703,995448,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Necrosis, Apoptotic; Study_ID: S020115",Other,,
1704,995449,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Hypertrophy; Study_ID: S020115",Other,,
1705,995450,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Lipid Accumulation, Macrovesicular; Study_ID: S020115",Other,,
1706,995451,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Myocyte, Degeneration; Study_ID: S020115",Other,,
1707,995452,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Myocyte, Lipid Accumulation; Study_ID: S020115",Other,,
1708,995453,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Degeneration; Study_ID: S020115",Other,,
1709,995454,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Perivascular Edema; Study_ID: S020115",Other,,
1710,995455,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Single Hepatocyte Necrosis; Study_ID: S020115,Other,,
1711,995456,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct Hyperplasia; Study_ID: S020115,Other,,
1712,995457,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Cytoplasm, Eosinophilia; Study_ID: S020115",Other,,
1713,995458,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Hypertrophy; Study_ID: S020115",Other,,
1714,995459,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Lipid Accumulation, Macrovesicular; Study_ID: S020115",Other,,
1715,995460,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S020115",Other,,
1716,995461,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Fibrosis; Study_ID: S020115",Other,,
1717,995462,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Left Ventricle, Fibrosis; Study_ID: S020115",Other,,
1718,995463,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Papillary Muscle, Cellular Infiltrate, Mixed Cell; Study_ID: S020115",Other,,
1719,995464,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Right Atrium, Cellular Infiltrate, Mononuclear Cell; Study_ID: S020115",Other,,
1720,995465,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Epicardium, Hyperplasia; Study_ID: S020115",Other,,
1721,995466,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Cellular Infiltrate, Mononuclear Cell; Study_ID: S020115",Other,,
1722,995467,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Necrosis, Fibrinoid; Study_ID: S020115",Other,,
1723,995468,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Perivascular Fibrosis; Study_ID: S020115",Other,,
1724,995469,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Nuclear Cytoplasmic Condensation; Study_ID: S020115,Other,,
1725,995470,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S020115",Other,,
1726,995471,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Lipid Accumulation, Microvesicular; Study_ID: S020115",Other,,
1727,995472,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Necrosis, Oncocytic; Study_ID: S020115",Other,,
1728,996052,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Multinucleated; Study_ID: S020115",Other,,
1729,996053,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Malignant Lymphoma; Study_ID: S020115,Other,,
1730,996054,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S020115",Other,,
1731,996055,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Neutrophilic; Study_ID: S020115",Other,,
1732,996056,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Left Ventricle, Cellular Infiltrate, Mononuclear Cell; Study_ID: S020115",Other,,
1733,996057,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Left Ventricle, Myocyte, Degeneration; Study_ID: S020115",Other,,
1734,996058,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Degeneration; Study_ID: S020115",Other,,
1735,996059,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Lipid Accumulation, Microvesicular; Study_ID: S020115",Other,,
1736,996060,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Oval Cell, Hyperplasia; Study_ID: S020115",Other,,
1737,996061,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Subcapsular, Fibrosis; Study_ID: S020115",Other,,
1738,996062,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Papillary Muscle, Cellular Infiltrate, Mononuclear Cell; Study_ID: S020115",Other,,
1739,996063,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Endocardium, Cellular Infiltrate, Mononuclear Cell; Study_ID: S020115",Other,,
1740,996064,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Tunica Media, Hypertrophy; Study_ID: S020115",Other,,
1741,997931,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Thrombus; Study_ID: S020115",Other,,
1742,997932,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Clear Cell Focus; Study_ID: S020115,Other,,
1743,997933,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Cytoplasm, Eosinophilia; Study_ID: S020115",Other,,
1744,997934,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Granulomatous; Study_ID: S020115",Other,,
1745,997935,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Left Atrium, Myocyte, Degeneration; Study_ID: S020115",Other,,
1746,997936,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Cellular Infiltrate, Mixed Cell; Study_ID: S020115",Other,,
1747,997937,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Interventricular Septum, Cellular Infiltrate, Mixed Cell; Study_ID: S020115",Other,,
1748,997938,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Interventricular Septum, Cellular Infiltrate, Mononuclear Cell; Study_ID: S020115",Other,,
1749,997939,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Interventricular Septum, Fibrosis; Study_ID: S020115",Other,,
1750,997940,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Interventricular Septum, Myocyte, Degeneration; Study_ID: S020115",Other,,
1751,997941,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Autolysis; Study_ID: S020115,Other,,
1752,997942,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct, Necrosis, Oncocytic; Study_ID: S020115",Other,,
1753,997943,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Glycogen Accumulation; Study_ID: S020115",Other,,
1754,997944,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Lipid Accumulation, Macrovesicular; Study_ID: S020115",Other,,
1755,997945,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Necrosis, Oncocytic; Study_ID: S020115",Other,,
1756,997946,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Necrosis, Oncocytic; Study_ID: S020115",Other,,
1757,997947,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Edema; Study_ID: S020115",Other,,
1758,997948,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Left Ventricle, Cellular Infiltrate, Mixed Cell; Study_ID: S020115",Other,,
1759,1003465,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Epicardium, Cellular Infiltrate, Mixed Cell; Study_ID: S020115",Other,,
1760,1003466,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Epicardium, Cellular Infiltrate, Mononuclear Cell; Study_ID: S020115",Other,,
1761,1003467,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S020115",Other,,
1762,1003468,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Diffuse, Hypertrophy; Study_ID: S020115",Other,,
1763,1003469,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Erythrophagocytosis; Study_ID: S020115",Other,,
1764,1003470,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Glycogen Accumulation; Study_ID: S020115",Other,,
1765,1003471,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Subcapsular, Necrosis, Oncocytic; Study_ID: S020115",Other,,
1766,1003472,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S020115",Other,,
1767,1003473,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S020115",Other,,
1768,1003474,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Left Atrium, Fibrosis; Study_ID: S020115",Other,,
1769,1003475,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Papillary Muscle, Myocyte, Degeneration; Study_ID: S020115",Other,,
1770,1003476,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Cellular Infiltrate, Mononuclear Cell; Study_ID: S020115",Other,,
1771,1003477,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct Dilatation; Study_ID: S020115,Other,,
1772,1003478,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Mesothelial Cell, Hyperplasia; Study_ID: S020115",Other,,
1773,1003479,1,3,,103171472,2907,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular Fibrosis; Study_ID: S020115,Other,,
1774,1003480,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Atrophy; Study_ID: S020115",Other,,
1775,1003481,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Degeneration; Study_ID: S020115",Other,,
1776,1003482,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Mineralization; Study_ID: S020115",Other,,
1777,1003483,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Necrosis, Oncocytic; Study_ID: S020115",Other,,
1778,1003484,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Glycogen Accumulation; Study_ID: S020115",Other,,
1779,1003485,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Necrosis, Apoptotic; Study_ID: S020115",Other,,
1780,1003486,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Subcapsular, Mineralization; Study_ID: S020115",Other,,
1781,1003487,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Extramedullary Hematopoiesis; Study_ID: S020115",Other,,
1782,1003488,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Fibrosis; Study_ID: S020115",Other,,
1783,1004074,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Cellular Infiltrate, Mixed Cell; Study_ID: S020115",Other,,
1784,1004075,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Left Atrium, Cellular Infiltrate, Mononuclear Cell; Study_ID: S020115",Other,,
1785,1004076,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S020115",Other,,
1786,1004077,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Necrosis, Apoptotic; Study_ID: S020115",Other,,
1787,1004078,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Diffuse, Cytoplasm, Eosinophilia; Study_ID: S020115",Other,,
1788,1004079,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Lipid Accumulation, Macrovesicular; Study_ID: S020115",Other,,
1789,1004080,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Lipid Accumulation, Microvesicular; Study_ID: S020115",Other,,
1790,1004081,1,3,,103171472,2907,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % water; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Necrosis, Apoptotic; Study_ID: S020115",Other,,
1791,1040642,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 171/8,Other,,
1792,1040643,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 171/8,Other,,
1793,1040644,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 171/8,Other,,
1794,1040645,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 171/9,Other,,
1795,1040646,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 171/9,Other,,
1796,1040647,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 171/9,Other,,
1797,1040648,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 171/9,Other,,
1798,1040649,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 171/9,Other,,
1799,1040650,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 171/10,Other,,
1800,1040651,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 171/10,Other,,
1801,1040652,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 171/10,Other,,
1802,1040653,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 171/10,Other,,
1803,1040654,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 171/10,Other,,
1804,1040655,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 171/11,Other,,
1805,1040656,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 171/11,Other,,
1806,1040657,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 171/11,Other,,
1807,1040658,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 171/11,Other,,
1808,1040659,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 171/11,Other,,
1809,1040660,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 171/12,Other,,
1810,1040661,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 171/12,Other,,
1811,1040662,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 171/12,Other,,
1812,1040663,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 171/12,Other,,
1813,1040664,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 171/12,Other,,
1814,1040665,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 171/13,Other,,
1815,1040666,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 171/13,Other,,
1816,1040667,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 171/13,Other,,
1817,1040668,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 171/13,Other,,
1818,1040669,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 171/13,Other,,
1819,1040670,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 171/14,Other,,
1820,1040671,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 171/14,Other,,
1821,1040672,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 171/14,Other,,
1822,1040673,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 171/14,Other,,
1823,1040674,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 171/14,Other,,
1824,1040675,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 171/15,Other,,
1825,1040676,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 171/15,Other,,
1826,1040677,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 171/15,Other,,
1827,1040678,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 171/15,Other,,
1828,1040679,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 171/15,Other,,
1829,1040680,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 171/16,Other,,
1830,1040681,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 171/16,Other,,
1831,1041350,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 171/16,Other,,
1832,1041351,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 171/16,Other,,
1833,1041352,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 171/16,Other,,
1834,1041353,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 172/5,Other,,
1835,1041354,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 172/5,Other,,
1836,1041355,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 172/5,Other,,
1837,1041356,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 172/5,Other,,
1838,1049418,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 627/12,Other,,
1839,1049419,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 627/12,Other,,
1840,1049420,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 627/12,Other,,
1841,1049421,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 627/13,Other,,
1842,1049422,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 627/13,Other,,
1843,1049423,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 627/13,Other,,
1844,1049424,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 627/13,Other,,
1845,1049425,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 627/13,Other,,
1846,1049426,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 627/14,Other,,
1847,1049427,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 627/14,Other,,
1848,1049428,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 627/14,Other,,
1849,1049429,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 627/14,Other,,
1850,1049430,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 627/14,Other,,
1851,1049431,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 627/15,Other,,
1852,1049432,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 627/15,Other,,
1853,1049433,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 627/15,Other,,
1854,1049434,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 627/15,Other,,
1855,1049435,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 627/15,Other,,
1856,1049436,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 627/16,Other,,
1857,1049437,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 627/16,Other,,
1858,1049438,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 627/16,Other,,
1859,1049439,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 627/16,Other,,
1860,1049440,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 627/16,Other,,
1861,1049903,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 171/5,Other,,
1862,1049904,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 171/5,Other,,
1863,1049905,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 171/5,Other,,
1864,1049906,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 171/5,Other,,
1865,1049907,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 171/5,Other,,
1866,1049908,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 171/6,Other,,
1867,1049909,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 171/6,Other,,
1868,1049910,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 171/6,Other,,
1869,1049911,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 171/6,Other,,
1870,1049912,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 171/6,Other,,
1871,1049913,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 171/7,Other,,
1872,1049914,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 171/7,Other,,
1873,1049915,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 171/7,Other,,
1874,1049916,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 171/7,Other,,
1875,1049917,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 171/7,Other,,
1876,1049918,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 171/8,Other,,
1877,1049919,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 171/8,Other,,
1878,1051237,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 172/5,Other,,
1879,1051238,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 172/6,Other,,
1880,1051239,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 172/6,Other,,
1881,1051240,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 172/6,Other,,
1882,1051241,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 172/6,Other,,
1883,1051242,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 172/6,Other,,
1884,1051243,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 172/7,Other,,
1885,1051244,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 172/7,Other,,
1886,1051245,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 172/7,Other,,
1887,1051246,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 172/7,Other,,
1888,1051247,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 172/7,Other,,
1889,1051248,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 172/8,Other,,
1890,1051249,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 172/8,Other,,
1891,1051441,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 172/8,Other,,
1892,1051442,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 172/8,Other,,
1893,1051443,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 172/8,Other,,
1894,1051444,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 172/9,Other,,
1895,1051445,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 172/9,Other,,
1896,1051446,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 172/9,Other,,
1897,1051447,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 172/9,Other,,
1898,1051448,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 172/9,Other,,
1899,1051449,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 172/10,Other,,
1900,1051450,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 172/10,Other,,
1901,1051451,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 172/10,Other,,
1902,1051452,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 172/10,Other,,
1903,1051453,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 172/10,Other,,
1904,1051454,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 172/11,Other,,
1905,1051455,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 172/11,Other,,
1906,1051456,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 172/11,Other,,
1907,1051457,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 172/11,Other,,
1908,1051458,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 172/11,Other,,
1909,1051459,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 172/12,Other,,
1910,1051460,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 172/12,Other,,
1911,1051461,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 172/12,Other,,
1912,1051462,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 172/12,Other,,
1913,1051463,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 172/12,Other,,
1914,1051464,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 172/13,Other,,
1915,1051465,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 172/13,Other,,
1916,1051466,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 172/13,Other,,
1917,1051467,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 172/13,Other,,
1918,1051468,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 172/13,Other,,
1919,1051469,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 172/14,Other,,
1920,1051470,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 172/14,Other,,
1921,1051471,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 172/14,Other,,
1922,1051472,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 172/14,Other,,
1923,1051473,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 172/14,Other,,
1924,1052286,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 172/15,Other,,
1925,1052287,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 172/15,Other,,
1926,1052288,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 172/15,Other,,
1927,1052289,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 172/15,Other,,
1928,1052290,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 172/15,Other,,
1929,1052291,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 172/16,Other,,
1930,1052292,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 172/16,Other,,
1931,1052469,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 172/16,Other,,
1932,1052470,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 172/16,Other,,
1933,1052471,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 172/16,Other,,
1934,1052472,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 627/5,Other,,
1935,1052473,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 627/5,Other,,
1936,1052474,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 627/5,Other,,
1937,1052475,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 627/5,Other,,
1938,1052476,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 627/5,Other,,
1939,1052477,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 627/6,Other,,
1940,1052478,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 627/6,Other,,
1941,1052479,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 627/6,Other,,
1942,1052480,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 627/6,Other,,
1943,1052481,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 627/6,Other,,
1944,1052482,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 627/7,Other,,
1945,1052483,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 627/7,Other,,
1946,1052484,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 627/7,Other,,
1947,1052485,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 627/7,Other,,
1948,1052486,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 627/7,Other,,
1949,1052487,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 627/8,Other,,
1950,1052488,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 627/8,Other,,
1951,1052489,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 627/8,Other,,
1952,1052490,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 627/8,Other,,
1953,1052491,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 627/8,Other,,
1954,1052492,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 627/9,Other,,
1955,1052493,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 627/9,Other,,
1956,1052494,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 627/9,Other,,
1957,1052495,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 627/9,Other,,
1958,1052496,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 627/9,Other,,
1959,1052497,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 627/10,Other,,
1960,1052498,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 627/10,Other,,
1961,1052499,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 627/10,Other,,
1962,1052500,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 627/10,Other,,
1963,1052501,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 627/10,Other,,
1964,1052502,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 627/11,Other,,
1965,1052503,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 627/11,Other,,
1966,1052504,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 627/11,Other,,
1967,1052505,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 627/11,Other,,
1968,1052506,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 627/11,Other,,
1969,1052507,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 627/12,Other,,
1970,1052508,1,2,,103171472,2907,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 627/12,Other,,
1971,1053194,1,1,,90341534,2907,Inactive,,,0.0132,Potency,Cell Proliferation Assay Versus the ED40515 IL2 Independent  ATL cell lines,Confirmatory,,
1972,1053195,1,1,,90341534,2907,Inactive,,,5.2576,Potency,Cell Proliferation Assay Versus the ED40515 IL2 Dependent  ATL cell lines,Confirmatory,,
1973,1079931,1,1,,103171472,2907,Unspecified,,,,,"Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]",Other,15646539.0,
1974,1079932,1,1,,103171472,2907,Unspecified,,,,,"Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]",Other,15646539.0,
1975,1079933,1,1,,103171472,2907,Unspecified,,,,,"Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source]",Other,15646539.0,
1976,1079934,1,1,,103171472,2907,Unspecified,,,,,"Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]",Other,15646539.0,
1977,1079935,1,1,,103171472,2907,Unspecified,,,,,"Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]",Other,15646539.0,
1978,1079936,1,1,,103171472,2907,Unspecified,,,,,"Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]",Other,15646539.0,
1979,1079937,1,1,,103171472,2907,Unspecified,,,,,"Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]",Other,15646539.0,
1980,1079938,1,1,,103171472,2907,Unspecified,,,,,"Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]",Other,15646539.0,
1981,1079939,1,1,,103171472,2907,Unspecified,,,,,"Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]",Other,15646539.0,
1982,1079940,1,1,,103171472,2907,Unspecified,,,,,"Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]",Other,15646539.0,
1983,1079941,1,1,,103171472,2907,Unspecified,,,,,"Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]",Other,15646539.0,
1984,1079942,1,1,,103171472,2907,Unspecified,,,,,"Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]",Other,15646539.0,
1985,1079943,1,1,,103171472,2907,Unspecified,,,,,"Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]",Other,15646539.0,
1986,1079944,1,1,,103171472,2907,Unspecified,,,,,"Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]",Other,15646539.0,
1987,1079945,1,1,,103171472,2907,Unspecified,,,,,Animal toxicity known. [column 'TOXIC' in source],Other,15646539.0,
1988,1079946,1,1,,103171472,2907,Unspecified,,,,,Presence of at least one case with successful reintroduction. [column 'REINT' in source],Other,15646539.0,
1989,1079947,1,1,,103171472,2907,Unspecified,,,,,Comments (NB not yet translated). [column 'COMMENTAIRES' in source],Other,15646539.0,
1990,1079948,1,1,,103171472,2907,Unspecified,,,,,"Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]",Other,15646539.0,
1991,1079949,1,1,,103171472,2907,Unspecified,,,,,Proposed mechanism(s) of liver damage. [column 'MEC' in source],Other,15646539.0,
1992,1083864,2,1,,103171472,2907,Unspecified,,,,,"Lipophilicity, log P of the compound",Other,,
1993,1083865,1,2,,103171472,2907,Unspecified,,,,,"Distribution coefficient, log D of the compound",Other,,
1994,1083866,1,2,,103171472,2907,Active,,,0.153,IC50,Antiproliferative activity against Homo sapiens (human) K562 cells after 48 hr by MTT assay,Confirmatory,,
1995,1085426,1,2,,103171472,2907,Active,,,0.09,IC50,Cytotoxicity against Homo sapiens (human) MDA-MB-231 cells after 48 hr by MTT assay,Confirmatory,,
1996,1085427,1,2,,103171472,2907,Active,,,0.24,IC50,Cytotoxicity against Homo sapiens (human) HepG2 cells after 48 hr by MTT assay,Confirmatory,,
1997,1085428,2,1,,103171472,2907,Unspecified,,,,,"Lipophilicity, log P of the compound",Other,,
1998,1085429,1,2,,103171472,2907,Active,,,0.15,IC50,Cytotoxicity against Homo sapiens (human) K562 cells after 48 hr by MTT assay,Confirmatory,,
1999,1086297,1,2,,103171472,2907,Unspecified,,,,,Growth inhibition of Homo sapiens (human) HepG2 cells at 10 uM after 48 hr by SRB assay,Other,,
2000,1086298,1,2,,103171472,2907,Unspecified,,,,,Growth inhibition of Homo sapiens (human) HCT15 cells at 10 uM after 48 hr by SRB assay,Other,,
2001,1086299,1,2,,103171472,2907,Unspecified,,,,,Growth inhibition of Homo sapiens (human) T47D cells at 10 uM after 48 hr by SRB assay,Other,,
2002,1086300,1,2,,103171472,2907,Unspecified,,,,,Growth inhibition of Homo sapiens (human) PA1 cells at 10 uM after 48 hr by SRB assay,Other,,
2003,1086301,1,2,,103171472,2907,Unspecified,,,,,Growth inhibition of Homo sapiens (human) NCI-H522 cells at 10 uM after 48 hr by SRB assay,Other,,
2004,1086917,1,2,,103171472,2907,Unspecified,,,,,Cytotoxicity against Homo sapiens (human) HepG2 cells assessed as growth inhibition at 1 x 10'-5 M after 48 hr by SRB assay,Other,,
2005,1086918,1,2,,103171472,2907,Unspecified,,,,,Cytotoxicity against Homo sapiens (human) HCT15 cells assessed as growth inhibition at 1 x 10'-5 M after 48 hr by SRB assay,Other,,
2006,1086919,1,2,,103171472,2907,Unspecified,,,,,Cytotoxicity against Homo sapiens (human) T47D cells assessed as growth inhibition at 1 x 10'-5 M after 48 hr by SRB assay,Other,,
2007,1086920,1,2,,103171472,2907,Unspecified,,,,,Cytotoxicity against Homo sapiens (human) PA1 cells assessed as growth inhibition at 1 x 10'-5 M after 48 hr by SRB assay,Other,,
2008,1086921,1,2,,103171472,2907,Unspecified,,,,,Cytotoxicity against Homo sapiens (human) NCI-H522 cells assessed as growth inhibition at 1 x 10'-5 M after 48 hr by SRB assay,Other,,
2009,1095201,1,2,,103171472,2907,Active,,,0.16,IC50,Cytotoxicity against Homo sapiens (human) MCF7 cells after 48 hr by trypan blue assay,Confirmatory,,
2010,1115687,1,2,,103171472,2907,Unspecified,,,,,Cytotoxicity against Homo sapiens (human) COLO320 cells at 156 ug/mL by MTT assay,Other,,
2011,1116277,1,2,,103171472,2907,Unspecified,,,,,Growth inhibition of Homo sapiens (human) PA1 cells at 10 uM after 48 hr by SRB assay,Other,,
2012,1116278,1,2,,103171472,2907,Unspecified,,,,,Growth inhibition of Homo sapiens (human) HepG2 cells at 10 uM after 48 hr by SRB assay,Other,,
2013,1116279,1,2,,103171472,2907,Unspecified,,,,,Growth inhibition of Homo sapiens (human) HCT15 cells at 10 uM after 48 hr by SRB assay,Other,,
2014,1116280,1,2,,103171472,2907,Unspecified,,,,,Growth inhibition of Homo sapiens (human) T47D cells at 10 uM after 48 hr by SRB assay,Other,,
2015,1116281,1,2,,103171472,2907,Unspecified,,,,,Growth inhibition of Homo sapiens (human) NCI-H522 cells at 10 uM after 48 hr by SRB assay,Other,,
2016,1116282,1,2,,103171472,2907,Unspecified,,,,,Cytotoxicity against Homo sapiens (human) HepG2 cells assessed as growth inhibition at 10 uM after 48 hr by SRB assay,Other,,
2017,1116283,1,2,,103171472,2907,Unspecified,,,,,Cytotoxicity against Homo sapiens (human) HCT15 cells assessed as growth inhibition at 10 uM after 48 hr by SRB assay,Other,,
2018,1116284,1,2,,103171472,2907,Unspecified,,,,,Cytotoxicity against Homo sapiens (human) PA1 cells assessed as growth inhibition at 10 uM after 48 hr by SRB assay,Other,,
2019,1116285,1,2,,103171472,2907,Unspecified,,,,,Cytotoxicity against Homo sapiens (human) NCI-H522 cells assessed as growth inhibition at 10 uM after 48 hr by SRB assay,Other,,
2020,1116286,1,2,,103171472,2907,Unspecified,,,,,Cytotoxicity against Homo sapiens (human) T47D cells assessed as growth inhibition at 10 uM after 48 hr by SRB assay,Other,,
2021,1123782,1,1,,103171472,2907,Unspecified,,,,,"Antitumor activity against mouse L1210 cells allografted in mouse assessed as increase in survival rate at 250 mg/kg, ip administered on day 1 measured on day 30 relative to control",Other,423194.0,
2022,1123786,1,1,,103171472,2907,Unspecified,,,,,"Toxicity in mouse allografted with mouse L1210 cells assessed as survival rate at 250 mg/kg, ip administered on day 1 measured on day 30 relative to control",Other,423194.0,
2023,1123791,1,1,,103171472,2907,Unspecified,,,,,Toxicity in mouse allografted with mouse ADJ/PC6 cells,Other,423194.0,
2024,1123792,1,1,,103171472,2907,Unspecified,,,,,Antitumor activity against mouse ADJ/PC6 cells allografted in mouse,Other,423194.0,
2025,1123793,1,1,,103171472,2907,Unspecified,,,,,"Therapeutic index, ratio of LD50 for mouse allografted with mouse ADJ/PC6 cells to ED90 for mouse ADJ/PC6 cells allografted in mouse",Other,423194.0,
2026,1123795,1,1,,103171472,2907,Unspecified,,,,,Cytotoxicity against rat Walker 256 cells assessed as growth inhibition in absence of microsomal activation,Other,423194.0,
2027,1123796,1,1,,103171472,2907,Unspecified,,,,,Cytotoxicity against rat Walker 256 cells assessed as growth inhibition in presence of microsomal activation,Other,423194.0,
2028,1130590,1,1,,103171472,2907,Unspecified,,,,,Antitumor activity against mouse P388 cells allografted in ip dosed mouse assessed as minimum effective dose administered as single dose,Other,490545.0,
2029,1130627,1,1,,103171472,2907,Unspecified,,,,,Antitumor activity against mouse P388 cells allografted in ip dosed mouse assessed as minimum effective dose administered as once each 4 days for 3 total injection,Other,490545.0,
2030,1130628,1,1,,103171472,2907,Unspecified,,,,,Toxicity in mouse P388 cells allografted ip dosed mouse assessed as maximum tolerated dose administered as single dose,Other,490545.0,
2031,1130629,1,1,,103171472,2907,Unspecified,,,,,Toxicity in mouse P388 cells allografted ip dosed mouse assessed as maximum tolerated dose administered as once each 4 days for 3 total injection,Other,490545.0,
2032,1130630,1,1,,103171472,2907,Unspecified,,,,,Antitumor activity against mouse P388 cells allografted in ip dosed mouse assessed as dose providing 40% increase in life span administered as single dose,Other,490545.0,
2033,1130631,1,1,,103171472,2907,Unspecified,,,,,Antitumor activity against mouse P388 cells allografted in ip dosed mouse assessed as dose providing 40% increase in life span administered as once each 4 days for 3 total injection,Other,490545.0,
2034,1130632,1,1,,103171472,2907,Unspecified,,,,,"Therapeutic index, ratio of MTD for mouse P388 cells allografted ip dosed mouse to MED for mouse P388 cells allografted in ip dosed mouse administered as single dose",Other,490545.0,
2035,1130633,1,1,,103171472,2907,Unspecified,,,,,"Therapeutic index, ratio of MTD for mouse P388 cells allografted ip dosed mouse to MED for mouse P388 cells allografted in ip dosed mouse administered as once each 4 days for 3 total injection",Other,490545.0,
2036,1132141,1,1,,103171472,2907,Unspecified,,,,,"Antileukemic activity against mouse L1210 cells allografted in BDF1 mouse assessed as mean survival time at 50 mg/kg, ip administered 24 hrs (Rvb 4.6 +/- 0.16 days)",Other,621716.0,
2037,1132142,1,1,,103171472,2907,Unspecified,,,,,"Antileukemic activity against mouse L1210 cells allografted in BDF1 mouse assessed as mean survival time at 100 mg/kg, ip administered 24 hrs (Rvb 4.6 +/- 0.16 days)",Other,621716.0,
2038,1132144,1,1,,103171472,2907,Unspecified,,,,,"Antileukemic activity against mouse L1210 cells allografted in BDF1 mouse assessed as mean survival time at 200 mg/kg, ip administered 24 hrs (Rvb 4.6 +/- 0.16 days)",Other,621716.0,
2039,1132145,1,1,,103171472,2907,Unspecified,,,,,"Antileukemic activity against mouse L1210 cells allografted in BDF1 mouse assessed as mean survival time at 400 mg/kg, ip administered 24 hrs (Rvb 4.6 +/- 0.16 days)",Other,621716.0,
2040,1132152,1,1,,103171472,2907,Unspecified,,,,,"Antileukemic activity against mouse L1210 cells allografted in BDF1 mouse assessed as increase in life span at 50 mg/kg, ip administered 24 hrs relative to control",Other,621716.0,
2041,1132153,1,1,,103171472,2907,Unspecified,,,,,"Antileukemic activity against mouse L1210 cells allografted in BDF1 mouse assessed as increase in life span at 100 mg/kg, ip administered 24 hrs relative to control",Other,621716.0,
2042,1132155,1,1,,103171472,2907,Unspecified,,,,,"Antileukemic activity against mouse L1210 cells allografted in BDF1 mouse assessed as increase in life span at 200 mg/kg, ip administered 24 hrs relative to control",Other,621716.0,
2043,1132156,1,1,,103171472,2907,Unspecified,,,,,"Antileukemic activity against mouse L1210 cells allografted in BDF1 mouse assessed as increase in life span at 400 mg/kg, ip administered 24 hrs relative to control",Other,621716.0,
2044,1132161,1,1,,103171472,2907,Unspecified,,,,,Antileukemic activity against mouse L1210 cells allografted in iv dosed BDF1 mouse assessed as survival over 60 days administered 24 hrs,Other,621716.0,
2045,1132162,1,1,,103171472,2907,Unspecified,,,,,Antileukemic activity against mouse L1210 cells allografted in ip dosed BDF1 mouse assessed as survival over 60 days administered 24 hrs,Other,621716.0,
2046,1132163,1,1,,103171472,2907,Unspecified,,,,,Antileukemic activity against mouse L1210 cells allografted in po dosed BDF1 mouse assessed as survival over 60 days administered 24 hrs,Other,621716.0,
2047,1132164,1,1,,103171472,2907,Unspecified,,,,,Antileukemic activity against mouse L1210 cells allografted in iv dosed BDF1 mouse assessed as maximum tolerated dose for survival over 60 days administered 24 hrs,Other,621716.0,
2048,1132165,1,1,,103171472,2907,Unspecified,,,,,Antileukemic activity against mouse L1210 cells allografted in ip dosed BDF1 mouse assessed as maximum tolerated dose for survival over 60 days administered 24 hrs,Other,621716.0,
2049,1132166,1,1,,103171472,2907,Unspecified,,,,,Antileukemic activity against mouse L1210 cells allografted in po dosed BDF1 mouse assessed as maximum tolerated dose for survival over 60 days administered 24 hrs,Other,621716.0,
2050,1132167,1,1,,103171472,2907,Unspecified,,,,,Ratio of Cmax to Cmin for antileukemic activity against mouse L1210 cells allografted in iv dosed BDF1 mouse assessed as survival over 60 days,Other,621716.0,
2051,1132168,1,1,,103171472,2907,Unspecified,,,,,Ratio of Cmax to Cmin for antileukemic activity against mouse L1210 cells allografted in ip dosed BDF1 mouse assessed as survival over 60 days,Other,621716.0,
2052,1132169,1,1,,103171472,2907,Unspecified,,,,,Ratio of Cmax to Cmin for antileukemic activity against mouse L1210 cells allografted in po dosed BDF1 mouse assessed as survival over 60 days,Other,621716.0,
2053,1148664,2,1,,103171472,2907,Unspecified,,,,,"Octanol-water partition coefficient, log P of the compound",Other,722720.0,
2054,1159389,1,2,,103171472,2907,Unspecified,,,,,"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.",Other,,
2055,1159390,1,2,,103171472,2907,Unspecified,,,,,"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.",Other,,
2056,1159510,3,1,,90341534,2907,Inactive,,,,Potency,Immunotoxin (HA22) sensitization/mitigation study. Vehicle arm (PBS),Confirmatory,,
2057,1159511,3,1,,90341534,2907,Inactive,,,,Potency,Immunotoxin (SS1P) sensitization/mitigation study - treatment arm,Confirmatory,,
2058,1159512,3,1,,90341534,2907,Inactive,,,,Potency,Immunotoxin (HA22) sensitization/mitigation study - treatment arm (low dose),Confirmatory,,
2059,1159513,3,1,,90341534,2907,Inactive,,,,Potency,Immunotoxin (SS1P) sensitization/mitigation study. Vehicle arm (DMEM),Confirmatory,,
2060,1159530,2,1,,90341534,2907,Inconclusive,,,0.0037,Potency,Immunotoxin (HA22) sensitization/mitigation study - treatment arm (High Dose),Confirmatory,,
2061,1159580,2,1,,268735309,2907,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
2062,1159580,2,1,,273002742,2907,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
2063,1159607,2,1,,312310352,2907,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
2064,1161646,1,1,,103171472,2907,Unspecified,,,,,Antitumor activity against mouse S180 cells implanted in mouse assessed as inhibition of tumor growth at 40 mg/kg,Other,25160837.0,
2065,1165765,1,1,,103171472,2907,Unspecified,,,,,"Antitumor activity against human H22 cells transplanted in ICR mouse assessed as tumor growth inhibition at 30 mg/kg, iv administered 7 days post tumor transplantation",Other,25247772.0,
2066,1165769,1,1,,103171472,2907,Unspecified,,,,,"Toxicity in human H22 cells transplanted ICR mouse assessed as mouse survival at 30 mg/kg, iv administered 7 days post tumor transplantation",Other,25247772.0,
2067,1165771,1,1,,103171472,2907,Unspecified,,,,,"Toxicity in human H22 cells transplanted ICR mouse assessed as mouse body weight at 30 mg/kg, iv administered 7 days post tumor transplantation (Rvb = 18.1 +/- 1g)",Other,25247772.0,
2068,1176855,1,1,,103171472,2907,Unspecified,,,,,"Antitumor activity against human H22 cells xenografted in ICR mouse assessed as tumor growth inhibition at 30 mg/kg, iv administered 7 days post inoculation measured at day 25 of tumor transplantation",Other,25529742.0,
2069,1197742,1,2,,103171472,2907,Unspecified,12643959.0,10599.0,,,Stimulation of human OATP1B1-mediated [3H]estrone 3-sulfate at 100 uM after 5 mins relative to control,Other,25618019.0,
2070,1197746,1,2,,103171472,2907,Unspecified,27734563.0,28234.0,,,Stimulation of human OATP1B3-mediated [3H]CCK-8 at 100 uM after 5 mins relative to control,Other,25618019.0,
2071,1200255,1,2,,103171472,2907,Unspecified,,,,,"Antitumor activity against mouse LLC cells allografted in C57BL/6 mouse assessed as tumor growth inhibition at 60 mg/kg, ip administerd for 14 days measured on day 15 relative to control",Other,25668341.0,
2072,1200596,1,1,,103171472,2907,Unspecified,,,,,"Antitumor activity against human HT-29 cells xenografted in BALB/c mouse assessed as reduction in tumor volume at 30 mg/kg, ip administered once daily for 18 days",Other,25689111.0,
2073,1200599,1,1,,103171472,2907,Unspecified,,,,,"Toxicity in human HT-29 cells xenografted BALB/c mouse assessed as change in body weight at 30 mg/kg, ip administered once daily for 18 days (Rvb = 2.5 g)",Other,25689111.0,
2074,1204815,1,1,,103171472,2907,Unspecified,,,,,"In vivo antitumor activity against human H22 cells xenografted in mouse assessed as tumor growth inhibitory ratio at 30 mg/kg, ip administered after 7 days of tumor transplantation measured at 25th day after tumor inoculation",Other,25984840.0,
2075,1204817,1,1,,103171472,2907,Unspecified,,,,,"Toxicity against mouse xenografted with human H22 cells assessed as body weight at 30 mg/kg, ip administered after 7 days of tumor transplantation (Rvb = 18.1 to 18.6 gms)",Other,25984840.0,
2076,1224817,1,1,,87150,2907,Inactive,,,,,Assays to identify small molecules inhibitory for eIF4E expression,Other,26144883.0,
2077,1224818,1,1,,312344363,2907,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway - cell viability counter screen,Confirmatory,,
2078,1224819,1,1,,312344363,2907,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway,Confirmatory,,
2079,1224820,1,1,,312344363,2907,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway,Confirmatory,,
2080,1224821,1,1,,312344363,2907,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC),Confirmatory,,
2081,1224822,1,1,,312344363,2907,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) ### cell viability counter screen,Confirmatory,,
2082,1224823,1,1,,312344363,2907,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC),Confirmatory,,
2083,1224824,1,1,,174007432,2907,Inactive,,,0.0042,Potency,High-throughput drug toxicity screening in the BPDCN cell line Gen2.2,Confirmatory,,
2084,1224825,1,1,,174007432,2907,Inactive,,,,Potency,High-throughput drug toxicity screening in the BPDCN cell line Cal-1,Confirmatory,,
2085,1224857,2,1,,174007432,2907,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
2086,1224857,2,1,,312344363,2907,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
2087,1224859,2,1,,90341534,2907,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
2088,1224859,2,1,,174007432,2907,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
2089,1224863,1,1,,176484326,2907,Inactive,90421313.0,1080.0,,IC50,Phenotypic Assay to Identify Small Molecules that Upregulate Production of hCFTR in HeLa Cells,Confirmatory,,
2090,1224863,1,1,,316920213,2907,Inactive,90421313.0,1080.0,,IC50,Phenotypic Assay to Identify Small Molecules that Upregulate Production of hCFTR in HeLa Cells,Confirmatory,,
2091,1224905,2,1,,92309008,2907,Inactive,120997.0,25643.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
2092,1224905,2,1,,92309008,2907,Inactive,74356043.0,55704.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
2093,1224905,2,1,,121361121,2907,Inactive,120997.0,25643.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
2094,1224905,2,1,,121361121,2907,Inactive,74356043.0,55704.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
2095,1228469,1,1,,103171472,2907,Unspecified,,,,,"Toxicity in KM mouse assessed as peripheral WBC number in blood per liter at 60 mg/kg, po single dose after 48 hrs (Rvb = 11.10 x 2.69/L x 10'-9)",Other,25905540.0,
2096,1228473,1,1,,103171472,2907,Unspecified,,,,,"Toxicity in KM mouse assessed as micronucleus frequency in bone marrow polychromatic erythrocyte at 60 mg/kg, po single dose after 48 hrs (Rvb = 2.20 +/- 0.84 %)",Other,25905540.0,
2097,1228477,1,1,,103171472,2907,Unspecified,,,,,"Toxicity in KM mouse assessed as peripheral WBC number in blood per liter at 30 mg/kg/day, po 5 doses (Rvb = 7.47 +/- 33.77 /L x 10'-9 cells)",Other,25905540.0,
2098,1228481,1,1,,103171472,2907,Unspecified,,,,,"Toxicity in KM mouse assessed as micronucleus frequency in bone marrow polychromatic erythrocyte at 30 mg/kg, po single dose after 48 hrs (Rvb = 1.20 +/- 0.45 %)",Other,25905540.0,
2099,1231141,1,1,,103171472,2907,Unspecified,,,,,"Antitumor activity against mouse CT26 cells implanted in mouse assessed as tumor growth inhibition at 114.9 umol/kg, ip qd administered for 7 days starting 24 hrs post tumor implantation measured after day 21 relative to control",Other,,
2100,1231148,1,1,,103171472,2907,Unspecified,,,,,"Antitumor activity against mouse LLC cells implanted in mouse assessed as tumor growth inhibition at 114.9 umol/kg, ip qd administered for 7 days starting 24 hrs post tumor implantation measured after day 21 relative to control",Other,,
2101,1259252,1,1,,174007432,2907,Inconclusive,169655958.0,,23.485,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (RDES),Confirmatory,,
2102,1259253,1,1,,174007432,2907,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC71),Confirmatory,,
2103,1259255,1,1,,174007432,2907,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (EW8),Confirmatory,,
2104,1259256,1,1,,174007432,2907,Active,169655958.0,,0.0021,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC32),Confirmatory,,
2105,1259310,1,1,,321942650,2907,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
2106,1259310,1,1,,332950540,2907,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
2107,1259325,1,2,,336954382,2907,Inactive,4504843.0,3763.0,,,Discovering small molecule activators of G protein-gated inwardly-rectifying potassium subunit 2 (GIRK2) containing channels utilizing methyl-2 4-pentanediol (MPD) for partial channel activation during screening,Screening,,
2108,1259354,1,1,,348469561,2907,Inactive,534286618.0,,,,Small-molecule inhibitors of ST2 (IL1RL1),Screening,,
2109,1259357,1,1,,90341534,2907,Inconclusive,,,,Potency,"Identifying Small Molecule Inhibitors of Pancreatic Cancer Stem Cells (A2780, Spheroid)",Confirmatory,,
2110,1259358,1,1,,90341534,2907,Inactive,,,,Potency,"Identifying Small Molecule Inhibitors of Pancreatic Cancer Stem Cells (SN12C, Adherent)",Confirmatory,,
2111,1259359,1,1,,90341534,2907,Inconclusive,,,,Potency,"Identifying Small Molecule Inhibitors of Pancreatic Cancer Stem Cells (Panc1, Spheroid)",Confirmatory,,
2112,1259360,1,1,,90341534,2907,Inactive,,,,Potency,"Identifying Small Molecule Inhibitors of Pancreatic Cancer Stem Cells (SN12C, Spheroid)",Confirmatory,,
2113,1259361,1,1,,90341534,2907,Inactive,,,,Activity at 9.921 uM,"Identifying Small Molecule Inhibitors of Pancreatic Cancer Stem Cells (A278, Adherent)",Confirmatory,,
2114,1259362,1,1,,90341534,2907,Inconclusive,,,,Potency,"Identifying Small Molecule Inhibitors of Pancreatic Cancer Stem Cells (Panc1, Adherent)",Confirmatory,,
2115,1259407,1,1,,363898138,2907,Inactive,,,,,CCRIS mutagenicity studies,Other,,
2116,1259408,1,1,,363894751,2907,Active,,,,,GENE-TOX mutagenicity studies,Other,,
2117,1259411,1,1,,363898138,2907,Inactive,,,,,CCRIS carcinogenicity studies,Other,,
2118,1259416,1,2,,340079771,2907,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
2119,1259416,1,2,,375178498,2907,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
2120,1259421,1,1,,340079771,2907,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
2121,1259421,1,1,,375178498,2907,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
2122,1259423,1,2,,354768902,2907,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
2123,1259423,1,2,,354931214,2907,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
2124,1259423,1,2,,354938729,2907,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
2125,1259423,1,2,,355015648,2907,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
